UREA AND THIOUREA SUBSTITUTED BICYCLES DERIVATIVES AS PESTICIDES

The present invention relates to compounds of formula (I), to processes for preparing them, to pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising them and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.

Heterocyclic compounds with pesticidal activity are known and described, for example, in

WO09/102736, W01 1/017505, WO12/109125, W013/1 16052, W013/1 16053 and WO14/01 1429. There have now been found novel pesticidally active urea and thiourea substituted bicycles derivatives.

Accordingly, as embodiment 1 of the invention, there is provided a compound of formula (I)

(I) or

a compound of formula (Γ)

wherein Q is selected from

(i)

(ϋ) „

(v)

A ¹ is N or CR ^A1

A ² is N or CR ^A2

A ³ is N or CR ^A3

A ⁴ is N or CR ^M

A ⁵ is N or CR ^A5

A ⁶ is N or CR ^A6

A ⁷ is 0 or S;

with the proviso that not more than four of A ¹ , A ² , A ³ , A ⁴ , A ⁵ and A ⁶ are N;

_R AI _R A2 _R A3 _R A4 _R A5 _{AND R} A6 _are independently selected from H, Ci-Cealkyl, C ₂ -C ₆ alkenyl, C ₂ - Cealkynyl, -(Co-Cealkyl)(C3-6cycloalkyl), Ci-Cehaloalkyl, C2-Cehaloalkenyl, C2-Cehaloalkynyl, -(Co- 6alkyl)(C ₃ -C ₆ halocycloalkyl), -(C ₃ -C6cycloalkyl)(Ci-C ₃ haloalkyl), -(Co- ₆ alkyl)-heterocyclyl, -(Co-Cealkyl)- heteroaryl, halogen, CN, -Ci-C4alkyl-CN, -C3-C6cycloalkyl-CN, NO2, Ci-C6alkoxy, Ci-C4haloalkoxy, Ci-C4alkoxy-Ci-C ₄ alkyl, -S-Ci-Cealkyl, -S(=0) ₂ Ci-Cealkyl,

-NH-Ci-Cealkyl, -N(Ci-C ₆ alkyl) ₂ , -NH-Cs-Cecycloalkyl, -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl),

Cealkyl, -C(=0)H

Cehaloalkyl) and

W is NR or O;

Y is O or S;

J is a 5- or 6-membered heteroaryl or heterocyclyl, wherein said heteroaryl and heterocyclyl is unsubstituted or substituted with one to three substituents independently selected from Ci-C6alkyl, C2- Cealkenyl, C2-C6alkynyl, -(Co-C6alkyl)C3-8cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-

Cehaloalkynyl, -(Co-6alkyl)C3-8halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co-C6alkyl)heterocyclyl, halogen, CN, -Ci-C ₄ alkyl-CN, -C ₃ -C ₆ cycloalkyl-CN, NO2, Ci-Cealkoxy, Ci-C ₄ haloalkoxy, -(Ci- C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-C ₆ alkyl, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealkyl, -S- Ci-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, -NH(Ci- Cealkyl), -N(C ₂ -C ₆ alkyl)2, -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl

CHO, -C(=0)(C ₂ -C ₆ alkoxy),

Cehaloalkyl) and

Ar and Ar ² are independently selected from phenyl and heteroaryl, wherein said phenyl and heteroaryl are unsubstituted or substituted by one to three substituents independently selected from Ci-Cealkyl, C ₂ -C ₆ alkenyl, C ₂ -C ₆ alkynyl, (Co-C ₆ alkyl)-C ₃ -6cycloalkyl, Ci-Cehaloalkyl, C ₂ -C ₆ haloalkenyl, C2-C6haloalkynyl, -(Co-C6alkyl)C3-6halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co- C ₆ alkyl)heterocyclyl, halogen, CN, -Ci-Cealkyl-CN, -Cs-Cecycloalkyl-CN, NO2, Ci-C ₆ alkoxy, Ci- Cehaloalkoxy, -(Ci-C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-C ₆ alkyl, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealkyl, - i-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, - -NH(Ci-C ₆ alkyl), -N(Ci-C ₆ alkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C ₃ - Cecycloalkyl), -

R and R ² are independently selected from H, Ci-C6-alkyl, Ci-C6-haloalkyl, -(Co-C6alkyl)C3-C6- cycloalkyl, -(Co-C6alkyl)C3-8halocycloalkyl, C2-C6-alkenyl, C2-C6haloalkenyl, C2-C6-alkynyl, C2- Cehaloalkynyl, -(Ci-C4alkyl)0(Ci-C ₄ alkyl), -S-Ci-Cealkyl, -S-Ci-Cehaloalkyl, -

Cealkoxy),

Cealkyl), provided that when R and R ² are different from H, R and R ² is unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, C3-C6halocycloalkyl, halogen, CN, NO2, Ci-C6alkoxy, Ci- Cehaloalkoxy, -S-Ci-Cealkyl, -NH(Ci- Cealkyl), -N(Ci-C ₆ alkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C4alkyl)(C ₃ -C ₆ cycloalkyl), - and -C(=0)(Ci-C ₆ alkyl); R ³ is selected from H, Ci-Ce-alkyl, -(Co-ealkylJCa-Ce-cycloalkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -C(=0)H, -C(=0)(Co- ₆ alkyl)(C3-C ₆ -cycloalkyl), -C(=0)0(Co-6alkyl)(C ₃ - C ₆ -cycloalkyl)-C(=0)(C2-C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ - alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), -(Co-6alkyl)phenyl, -(Co-6alkyl)-0-phenyl, -C(=0)-(Co-C ₆ -alkyl)(heteroaryl), -C(=0)-(Co-C ₆ -alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)(heteroaryl), -(Co-C ₆ - alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)-0-(heteroaryl), -(Co-C ₆ -alkyl)-0-(heterocyclyl), -(Ci-C ₆ - alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl)-0-(Ci- Ce-alkyl), -(Ci-C6-alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -haloalkyl), -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)- N(R ^3a )C(=0)-0-(Co- ₆ alkyl)-phenyl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)- heteroaryl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)-heterocyclyl, -(Ci-Ce-alkyl)-

-(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C6-alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)- C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heteroaryl, -(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heterocyclyl, -(Ci-C ₆ - alkyl)-C(=0)-heteroaryl,

N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b ))(C(=0)OH), -(Ci-C6-alkyl)-C(=0)-N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b )), - (Ci-C6-alkyl)-C(=0)-N(R ^3a )(Ci-C ₆ -alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)-C(=0)-N(R ^3a )(Ci- C ₆ -alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl)(C(=0)OH), -(Ci-C ₆ -alkyl)-C(=0)-(Co-C ₆ -alkyl)heteroaryl-C(=0)- 0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)-C(=0)-(Co-C ₆ -alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)-

cycloalkyl),

alkyl)heterocyclyl, -(Ci-C6-alkyl)-0-C(=0)-(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Co-Ce-alkyl)- _{N R} 3a _R 3b .(d-Ce-alky -O-iCo-Ce-alky heteroaryl and -(Ci-C ₆ -alkyl)-0-(Co-C ₆ -alkyl)heterocyclyl;

wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl are unsubstituted or substituted with one or more substituents independently selected from halogen, CN, NO2, NR ^3a R ^3b , Ci-C6-alkyl, Ci-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl), -S(=0) ₂ (Ci-C6-alkyl),

Ce-alkyl), -(Ci-C ₆ -alkyl)NR ^3a R ^3b , -

C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), - (Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^3a R ^3b , -S(=0) ₂ NR ^3a R ^3b , heteroaryl and heterocyclyl; Z is a 4- to 7-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from halogen, CN, N0 ₂ , oxo, hydroxy, -NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci-Ce- haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

haloalkyl), -C(=0)H, -C(=0)OH, -C(=0)NR ^Za R ^Zb , - (Ci-C ₆ -alkyl)NR ^Za R ^Zb , - -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ - phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl substituent is unsubstituted or substituted with one or more substituents independently selected from halogen, CN, N0 ₂ , NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci- Ce-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

alkyl), -0-S(=0) ₂ (Ci-C6-alkyl), -C(=0)H , -C(=0)OH , -C(=0)NR ^Za R ^Zb , -(Ci- C ₆ -alkyl)NR ^Za R ^Zb ,

haloalkyl), -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ - Ce-alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl),

Ce-alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(=0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

_R 3a _R 3b _R za _{and R} zb _are independently selected from H, Ci-Ce-alkyl, Ci-Ce-haloalkyl, C ₃ -C ₆ - cycloalkyl and Ci-C6-alkoxy;

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Definitions:

The term 'halogen' as used herein refers to a fluoro, chloro, bromo or iodo.

As used herein, the term "C3-C6alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to six carbon atoms, and which is attached to the rest of the molecule by a single bond. The term "Ci-4alkyl" is to be construed accordingly. Examples of d ealkyl include, but are not limited to, methyl, (R)- methyl, ethyl, n-propyl, 1-methylethyl (iso-propyl), n-butyl, n-pentyl and 1 ,1-dimethylethyl (t-butyl).

As used herein, the term "C3-C6haloalkyl" refers to a C3-C6alkyl radical, as defined above, substituted with one or more of the same or different halogen atoms, as defined above. Examples of C3- Cehaloalkyl include, but are not limited to, trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 1 ,3-dibromopropan-2-yl, 3-bromo-2-fluoropropyl and 1 ,4,4-trifluorobutan-2-yl.

As used herein, the term "C3-C6-cycloalkyl" refers to a saturated monocyclic hydrocarbon ring of 3 to 6 carbon atoms. Examples of such groups include cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. If a different number of carbon atoms is specified, then the definition is to be amended accordingly. As used herein, the term "C3-C6halocycloalkyl" refers to a C3-C6cycloalkyl radical, as defined above, substituted with one or more of the same or different halogen atoms, as defined above. Examples of C3-C6halocycloalkyl include, but are not limited to trifluorocyclopropyl, difluorobutyl, fluorocyclo and trichlorocyclohexyl. As used herein, the term "C2-C6alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond, having from two to six carbon atoms, which is attached to the rest of the molecule by a single bond. The term "C2-C4alkenyl" is to be construed accordingly. Examples of C2-C6alkenyl include, but are not limited to, ethenyl, prop-1-enyl, but-1 -enyl, pent-1 -enyl, pent-4-enyl and penta-1 ,4-dienyl.

As used herein, the term 'C2-C6haloalkenyl' as used herein refers to a C2-C6 alkenyl radical, as defined herein, substituted with one or more of the same or different halogen atoms, e.g for example, 2,2-difluorovinyl or 1 ,2-dichloro-2-fluoro-vinyl.

As used herein, the term "C2-C6alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond. The term "C2-C6alkynyl" is to be construed accordingly. Examples of C2-C6alkynyl include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl, pent-1 -ynyl, pent-4-ynyl and penta-1 ,4-diynyl.

As used herein, the term 'C2-C6haloalkynyl' as used herein refers to a C2-C6 alkynyl radical, as defined herein, substituted with one or more of the same or different halogen atoms, for example 1-chloro- prop-2-ynyl.

As used herein, the term "Ci-C6 alkoxyCi-C6 alkyl" as used herein refers to an -Ci-C6alkyl-0-Ci- Cealkyl is as defined above. Examples of such groups include methoxyethyl, methoxypropyl, ethoxypropyl. As used herein, the term "heteroaryl" refers to a 5- or 6-membered aromatic monocyclic ring radical which comprises 1 , 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heteroaryl radical may be bonded via a carbon atom or heteroatom. Examples of heteroaryl include, but are not limited to, furyl, pyrrolyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl or pyridyl.

As used herein, the term "heterocyclyl" or "heterocyclic" refers to a stable 5- or 6-membered non- aromatic monocyclic ring radical which comprises 1 , 2, or 3, heteroatoms individually selected from nitrogen, oxygen and sulfur. The heterocyclyl radical may be bonded via a carbon atom or heteroatom. Examples of heterocyclyl include, but are not limited to, azetidinyl, oxetanyl, pyrrolinyl, pyrrolidyl, tetrahydrofuryl, tetrahydrothienyl, piperidyl, piperazinyl, tetrahydropyranyl, morpholinyl or perhydroazepinyl.

The presence of one or more C=N double bonds in a compound of formula (I) means that the compounds may occur in E or Z isomeric forms. Formula (I) is intended to include all those possible stereoisomeric forms and mixtures thereof. The presence of one or more possible asymmetric carbon atoms in a compound of formula (I) means that the compounds may occur in optically stereoisomeric forms, i.e. enantiomeric or diastereomeric forms. Also atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible stereoisomeric forms and mixtures thereof. The present invention includes all those possible stereoisomeric forms and mixtures thereof for a compound of formula (I). Likewise, formula (I) is intended to include all possible tautomers. The present invention includes all possible tautomeric forms for a compound of formula (I). In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as a N-oxide or in salt form, e.g. an agronomically usable salt form.

Embodiment 2: A compound according to embodiment 1 , of formula (I)

(I)

wherein Q is selected from

(i)

(iii)

A ¹ is N or CR ^A ;

A ² is N or CR ^A2 ;

A ³ is N or CR ^A3 ;

A ⁴ is N or CR ^M ;

A ⁵ is N or CR ^A5 ;

A ⁶ is N or CR ^A6 ;

with the proviso that not more than four of A ¹ , A ² , A ³ , A ⁴ , A ⁵ and A ⁶ are N;

_R AI _R A2 _R A3 _R A4 _R A5 _{AND R} A6 _are independently selected from H, O-Cealk l, C ₂ -C ₆ alkenyl, C ₂ -

Cealkynyl, -(Co-C6alkyl)(C3-6cycloalkyl), Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, -(Co- 6alkyl)(C3-C6halocycloalkyl), -(C3-C6cycloalkyl)(Ci-C3haloalkyl), -(Co-6alkyl)-heterocyclyl, -(Co-C6alkyl)- heteroaryl, halogen, CN, -Ci-C4alkyl-CN, -Cs-Cecycloalkyl-CN, NO2, Ci-Cealkoxy, Ci-C4haloalkoxy, Ci-C4alkoxy-Ci-C ₄ alkyl, -S-Ci-Cealkyl, -S(=0) ₂ Ci-Cealkyl,

-NH-Ci-Cealkyl, -N(Ci-C ₆ alkyl) ₂ , -NH-Cs-Cecycloalkyl, -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl),

Cealkyl, -C(=0)H

Cehaloalkyl) and

W is NR or O;

Y is O or S; J is a 5- or 6-membered heteroaryl or heterocyclyl, wherein said heteroaryl and heterocyclyl is unsubstituted or substituted with one to three substituents independently selected from Ci-C6alkyl, C2- Cealkenyl, C2-C6alkynyl, -(Co-C6alkyl)C3-8cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2- Cehaloalkynyl, -(Co-6alkyl)C3-8halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co-C6alkyl)heterocyclyl, halogen, CN, -Ci-C ₄ alkyl-CN, -C ₃ -C ₆ cycloalkyl-CN, NO2, Ci-Cealkoxy, Ci-C ₄ haloalkoxy, -(Ci-

C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-Cealk l, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealk l, -S- O-Cehaloalk l, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, -NH(Ci- Cealkyl), -N(C ₂ -C ₆ alkyl)2, -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl),

CHO, -C(=0)(C ₂ -C ₆ alkoxy), -C(=0)NH(Ci- Cehaloalkyl) and

Ar ¹ and Ar ² are independently selected from phenyl, thienyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, furanyl, pyrazolyl, thiazolyl, imidazolyl, oxazolyl and isoxazolyl, wherein said phenyl, thienyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, furanyl, pyrazolyl, thiazolyl, imidazolyl, oxazolyl and isoxazolyl are unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, C2- Cealkenyl, C2-C6alkynyl, (Co-C6alkyl)-C3-6cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2- Cehaloalkynyl, -(Co-C6alkyl)C3-6halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co- C ₆ alkyl)heterocyclyl, halogen, CN, -Ci-Cealkyl-CN, -Cs-Cecycloalkyl-CN , NO2, Ci-C ₆ alkoxy, Ci- Cehaloalkoxy, -(Ci-C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-Cealkyl, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealkyl, - -S-Ci-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, - S(=0)(=NH)Ci-Cehaloalkyl, -NH(Ci-Cealkyl), -N(Ci-Cealkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C ₃ - Cecycloalkyl), - C(=0)NH(Ci-Cealkyl), and -C(=0)N(Ci-Cealkyl) ₂ ;

R and R ² are independently selected from H, Ci-C6-alkyl, Ci-C6-haloalkyl, -(Co-C6alkyl)C3-C6- cycloalkyl, -(Co-C6alkyl)C3-8halocycloalkyl, C2-C6-alkenyl, C2-C6haloalkenyl, C2-C6-alkynyl, C2- Cehaloalkynyl, -(Ci-C4alkyl)0(Ci-C ₄ alkyl), -S-Ci-Cealkyl, -S-Ci-Cehaloalkyl, - S(=0) ₂ -Ci-Cealkyl, -S(=0) ₂ -Ci-Cehaloalkyl, -C(=0)(Ci-Cealkyl), -C(=0)(Ci- Cealkoxy), -C(=0)NH(Ci-Cealkyl), -0-C(=0)(Ci-Cealkoxy), -0-C(=0)NH(Ci- Cealkyl), -0-C(=0)N(Ci-Cealkyl) ₂ and -C(=N-Ci-C4alkoxy)-Ci-C ₄ alkyl; provided that when R and R ² are different from H, R and R ² is unsubstituted or substituted by one to three substituents independently selected from Ci-Cealkyl, C ₂ -C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-Cehaloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, C3-C6halocycloalkyl, halogen, CN, NO2, Ci-C6alkoxy, Ci- Cehaloalkoxy, -S-Ci-Cealkyl, -S(=0)(=NH)Ci-Cealkyl, -NH(Ci- Cealkyl), -N(Ci-C ₆ alkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C4alkyl)(C ₃ -C ₆ cycloalkyl), -C(=0)(Ci-Cealkyl), - -C(=0)NH(Ci-Cealkyl) and -C(=0)(Ci-Cealkyl);

R ³ is selected from H, Ci-Ce-alkyl, -(Co-ealkylJCa-Ce-cycloalkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -C(=0)H, -C(=0)(Ci-Ce-alkyl), -C(=0)0(Ci-Ce-alkyl), -C(=0)(Co- ₆ alkyl)(C3-C ₆ -cycloalkyl), -C(=0)0(Co-6alkyl)(C ₃ - C ₆ -cycloalkyl)-C(=0)(C2-C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ - alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), -(Co-ealkyl)phenyl, -(Co-6alkyl)-0-phenyl, -C(=0)-(Co-C ₆ -alkyl)(heteroaryl), -C(=0)-(Co-C ₆ -alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)(heteroaryl), -(Co-Ce- alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)-0-(heteroaryl), -(Co-C ₆ -alkyl)-0-(heterocyclyl), -(Ci-Ce- alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl)-0-(Ci- Ce-alkyl), -(Ci-C6-alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -haloalkyl), -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)- N(R ^3a )C(=0)-0-(Co- ₆ alkyl)-phenyl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)- heteroaryl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)-heterocyclyl, -(Ci-Ce-alkyl)-

-(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C6-alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)- C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heteroaryl, -(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heterocyclyl, -(Ci-C ₆ - alkyl)-C(=0)-heteroaryl,

N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b ))(C(=0)OH), -(Ci-C6-alkyl)-C(=0)-N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b )), - (Ci-C ₆ -alkyl)-C(=0)-N(R ^3a )(Ci-C6-alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)-C(=0)-N(R ^3a )(Ci- C ₆ -alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl)(C(=0)OH), -(Ci-C ₆ -alkyl)-C(=0)-(Co-C ₆ -alkyl)heteroaryl-C(=0)- 0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)-C(=0)-(Co-C ₆ -alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)-

cycloalkyl),

alkyl)heterocyclyl, -(Ci-C6-alkyl)-0-C(=0)-(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Co-Ce-alkyl)- _{N R} 3a _R 3b .(d-Ce-alky -O-iCo-Ce-alky heteroaryl and -(Ci-C ₆ -alkyl)-0-(Co-C ₆ -alkyl)heterocyclyl;

wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl are unsubstituted or substituted with one or more substituents independently selected from halogen, CN, NO2, NR ^3a R ^3b , Ci-C6-alkyl, Ci-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl), -S(=0) ₂ (Ci-C6-alkyl),

Ce-alkyl), -(Ci-C ₆ -alkyl)NR ^3a R ^3b , -

C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), - (Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^3a R ^3b , -S(=0) ₂ NR ^3a R ^3b , heteroaryl and heterocyclyl;

Z is a 4- to 7-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from halogen, CN, N0 ₂ , oxo, hydroxy, -NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci-Ce- haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

haloalkyl), -C(=0)H, -C(=0)OH, -C(=0)NR ^Za R ^Zb , - (Ci-C ₆ -alkyl)NR ^Za R ^Zb , - -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl),

phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl substituent is unsubstituted or substituted with one or more substituents independently selected from halogen, CN, N0 ₂ , NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci- Ce-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

alkyl), -C(=0)H, -C(=0)OH, -C(=0)NR ^Za R ^Zb , -(Ci- C ₆ -alkyl)NR ^Za R ^Zb ,

haloalkyl), -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ - Ce-alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl),

Ce-alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(=0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

_R 3a _R 3b _R za _{and R} zb _are independently selected from H, Ci-Ce-alkyl, Ci-Ce-haloalkyl, C ₃ -C ₆ - cycloalkyl and Ci-C6-alkoxy;

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 2.1 : A compound according to embodiment 1 , of formula (Γ)

wherein Q is selected from

(i)

(iii)

(iv)

A ¹ is N or CR ^A ;

A ² is N or CR ^A2 ;

A ³ is N or CR ^A3 ;

A ⁴ is N or CR ^M ;

A ⁵ is N or CR ^A5 ;

A ⁶ is N or CR ^A6 ;

with the proviso that not more than four of A ¹ , A ² , A ³ , A ⁴ , A ⁵ and A ⁶ are N;

_R AI _R A2 _R A3 _R A4 _R A5 _{AND R} A6 _are independently selected from H, O-Cealk l, C ₂ -C ₆ alkenyl, C ₂ -

Cealkynyl, -(Co-C6alkyl)(C3-6cycloalkyl), Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, -(Co-

6alkyl)(C3-C6halocycloalkyl), -(C3-C6cycloalkyl)(Ci-C3haloalkyl), -(Co-6alkyl)-heterocyclyl, -(Co-C6alkyl)- heteroaryl, halogen, CN, -Ci-C4alkyl-CN, -C3-C6cycloalkyl-CN, NO2, Ci-C6alkoxy, Ci-C4haloalkoxy,

Ci-C4alkoxy-Ci-C ₄ alkyl, -S-Ci-Cealkyl, -S(=0) ₂ Ci-Cealkyl,

-NH-Ci-Cealkyl, -N(Ci-C ₆ alkyl) ₂ , -NH-Cs-Cecycloalkyl, -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl),

Cealkyl, -C(=0)H

Cehaloalkyl) and

W is NR or O;

Y is O or S;

J is a 5- or 6-membered heteroaryl or heterocyclyl, wherein said heteroaryl and heterocyclyl is unsubstituted or substituted with one to three substituents independently selected from Ci-C6alkyl, C2- Cealkenyl, C2-C6alkynyl, -(Co-C6alkyl)C3-8cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2- Cehaloalkynyl, -(Co-6alkyl)C3-8halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co-C6alkyl)heterocyclyl, halogen, CN, -Ci-C ₄ alkyl-CN, -C ₃ -C ₆ cycloalkyl-CN, NO2, Ci-C ₆ alkoxy, Ci-C ₄ haloalkoxy, -(Ci- C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-C ₆ alkyl, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealkyl, -S- Ci-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, -NH(Ci- Cealkyl), -N(C ₂ -C ₆ alkyl)2, -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl), -C(=0)(Ci-C ₆ alkyl), CHO, -C(=0)(C ₂ -C ₆ alkoxy), -C(=0)NH(Ci- Cehaloalkyl) and

Ar ¹ and Ar ² are independently selected from phenyl, thienyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, furanyl, pyrazolyl, thiazolyl, imidazolyl, oxazolyl and isoxazolyl, wherein said phenyl, thienyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, furanyl, pyrazolyl, thiazolyl, imidazolyl, oxazolyl and isoxazolyl are unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, C2- Cealkenyl, C2-C6alkynyl, (Co-C6alkyl)-C3-6cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2- Cehaloalkynyl, -(Co-C6alkyl)C3-6halocycloalkyl, -C3-C6cycloalkyl-Ci-C3haloalkyl, -(Co- C ₆ alkyl)heterocyclyl, halogen, CN, -Ci-Cealkyl-CN, -Cs-Cecycloalkyl-CN, NO2, Ci-C ₆ alkoxy, Ci- Cehaloalkoxy, -(Ci-C4alkyl)(Ci-C ₄ alkoxy), -S-Ci-Cealkyl, -S(0)-Ci-C ₆ alkyl, -S(=0) ₂ Ci-Cealkyl, - i-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, - -NH(Ci-C ₆ alkyl), -N(Ci-C ₆ alkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C ₆ alkyl)(C ₃ - Cecycloalkyl), -

R and R ² are independently selected from H, Ci-C6-alkyl, Ci-C6-haloalkyl, -(Co-C6alkyl)C3-C6- cycloalkyl, -(Co-C6alkyl)C3-8halocycloalkyl, C2-C6-alkenyl, C2-C6haloalkenyl, C2-C6-alkynyl, C2- Cehaloalkynyl, -(Ci-C4alkyl)0(Ci-C ₄ alkyl), -S-Ci-Cealkyl, -S-Ci-Cehaloalkyl, -

Cealkoxy Cealkoxy), -0-C(=0)NH(Ci- Cealkyl), provided that when R and R ² are different from H, R and R ² is unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, C3-C6halocycloalkyl, halogen, CN, NO2, Ci-C6alkoxy, Ci- Cehaloalkoxy, -S-Ci-Cealkyl, -S(=0)(=NH)Ci-Cealkyl, -NH(Ci- Cealkyl), -N(Ci-C ₆ alkyl) ₂ , -NH(C ₃ -C ₆ cycloalkyl), -N(Ci-C4alkyl)(C ₃ -C ₆ cycloalkyl), -C(=0)(Ci-Cealkyl), - -C(=0)NH(Ci-Cealkyl) and -C(=0)(Ci-Cealkyl);

R ³ is selected from H, Ci-Ce-alkyl, -(Co-ealkylJCa-Ce-cycloalkyl, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -C(=0)H, -C(=0)(Ci-Ce-alkyl), -C(=0)0(Ci-Ce-alkyl), -C(=0)(Co- ₆ alkyl)(C3-C ₆ -cycloalkyl), -C(=0)0(Co-6alkyl)(C ₃ - C ₆ -cycloalkyl)-C(=0)(C2-C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ - alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), -(Co-ealkyl)phenyl, -(Co-6alkyl)-0-phenyl, -C(=0)-(Co-C ₆ -alkyl)(heteroaryl), -C(=0)-(Co-C ₆ -alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)(heteroaryl), -(Co-Ce- alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)-0-(heteroaryl), -(Co-C ₆ -alkyl)-0-(heterocyclyl), -(Ci-Ce- alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)OC(=0)(Ci-C ₆ -alkyl)-0-(Ci-C ₆ -alkyl)-0-(Ci- Ce-alkyl), -(Ci-Ce-alkyl)OC(=0)(Ci-Ce-alkyl)-0-(Ci-Ce-haloalkyl) _I -(Ci-Ce-alkyl)OC(=0)(Ci-Ce-alkyl)- N(R ^3a )C(=0)-0-(Co- ₆ alkyl)-phenyl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)- heteroaryl, -(Ci-C ₆ -alkyl)OC(=0)(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Co-6alkyl)-heterocyclyl, -(Ci-Ce-alkyl)-

-(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C6-alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)- C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heteroaryl, -(Ci-C ₆ -alkyl)-C(=0)N(R ^3a )-(Co-C ₆ -alkyl)-heterocyclyl, -(Ci-Ce- alkyl)-C(=0)-heteroaryl, -(Ci-C ₆ -alkyl)-C(=0)-(Co-C ₆ -alkyl)heterocyclyl, -(Ci-C ₆ -alkyl)-C(=0)- N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b ))(C(=0)OH), -(Ci-C6-alkyl)-C(=0)-N(R ^3a )(Ci-C ₆ -alkyl)(N(R ^3a )(R ^3b )), - (Ci-C6-alkyl)-C(=0)-N(R ^3a )(Ci-C ₆ -alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)-C(=0)-N(R ^3a )(Ci- C ₆ -alkyl)N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl)(C(=0)OH), -(Ci-C ₆ -alkyl)-C(=0)-(Co-C ₆ -alkyl)heteroaryl-C(=0)- 0-(Ci-C ₆ -alkyl), -(Ci-C6-alkyl)-C(=0)-(Co-C ₆ -alkyl)-heterocyclyl-C(=0)-0-(Ci-C ₆ -alkyl), -(Ci-Ce-alkyl)-

cycloalkyl),

alkyl)heterocyclyl, -(Ci-C6-alkyl)-0-C(=0)-(Ci-C ₆ -alkyl)-N(R ^3a )C(=0)-0-(Ci-C ₆ -alkyl), -(Co-Ce-alkyl)- _{N R} 3a _R 3b .(d-Ce-alky -O-iCo-Ce-alky heteroaryl and -(Ci-C ₆ -alkyl)-0-(Co-C ₆ -alkyl)heterocyclyl;

wherein each alkyl, cycloalkyi, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl are unsubstituted or substituted with one or more substituents independently selected from halogen, CN, NO2, NR ^3a R ^3b , Ci-C6-alkyl, Ci-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl), -S(=0) ₂ (Ci-C6-alkyl),

Ce-alkyl), -(Ci-C ₆ -alkyl)NR ^3a R ^3b , -

C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), - (Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl), -C(=0)(Ci-C ₆ -alkyl)C(=0)0(Ci-C ₆ -alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^3a R ^3b , -S(=0) ₂ NR ^3a R ^3b , heteroaryl and heterocyclyl; Z is a 4- to 7-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from halogen, CN, N0 ₂ , oxo, hydroxy, -NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci-Ce- haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

haloalkyl), -C(=0)H, -C(=0)OH, -C(=0)NR ^Za R ^Zb , - (Ci-C ₆ -alkyl)NR ^Za R ^Zb , - -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ -C ₆ -alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl),

phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

wherein each alkyl, cycloalkyi, alkenyl, alkynyl, phenyl, heteroaryl and heterocyclyl substituent is unsubstituted or substituted with one or more substituents independently selected from halogen, CN, N0 ₂ , NR ^Za R ^Zb , Ci-Ce-alkyl, Ci-Ce-haloalkyl, Cs-Ce-cycloalkyl, Cs-Ce-halocycloalkyl, Ci-Ce-alkoxy, Ci- Ce-haloalkoxy, C ₂ -C ₆ -alkenyl, C ₂ -C ₆ -alkynyl, -S-(Ci-C ₆ -alkyl),

alkyl), -C(=0)H, -C(=0)OH, -C(=0)NR ^Za R ^Zb , -(Ci- C ₆ -alkyl)NR ^Za R ^Zb ,

haloalkyl), -C(=0)(C ₃ -C ₆ -cycloalkyl), -C(=0)0(C ₃ -C ₆ -cycloalkyl), -C(=0)(C ₂ -C ₆ -alkenyl), -C(=0)0(C ₂ - Ce-alkenyl), -(Ci-C ₆ -alkyl)0(Ci-C ₆ -alkyl), -(Ci-C ₆ -alkyl)S(Ci-C ₆ -alkyl),

Ce-alkyl), phenyl, -O-phenyl, -Si(Ci-C ₆ -alkyl) ₃ , -S(=0)NR ^Za R ^Zb , -S(=0) ₂ NR ^Za R ^Zb , heteroaryl and heterocyclyl;

R ^3a , R ^3b , R ^Za and R ^Zb are independently selected from H, Ci-Ce-alkyl, Ci-Ce-haloalkyl, C ₃ -C ₆ - cycloalkyl and Ci-C6-alkoxy;

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof. As used herein, when one embodiment refers to several other embodiments by using the term

"according to any one of", for example "according to any one of embodiments 1 to 23",

then said embodiment refers not only to embodiments indicated by integers such as 1

and 2 but also to embodiments indicated by numbers with a decimal component such as 23.1 , 23.2,

23.3, 23.4, 23.20, 23.25, 23.30.

Embodiment 3: The compound according to embodiment 1 or 2, of formula (la)

Embodiment 4: The compound according to embodiment 1 or 2, of formula (lb)

(lb).

Embodiment 5: The compound according to embodiment 1 or 2, of formula (lc)

(lc).

Embodiment 6: The compound according to embodiment 1 or 2, of formula (Id)

Embodiment 7: The compound according to embodiment 1 or 2, of formula (le)

(le).

Embodiment 7.1 : The compound according to embodiment 1 or 2, of formula (If)

Embodiment 8: The compound according to any one of embodiments 1 to 7, wherein

Ar ¹ is selected from phenyl, furanyl, pyridazinyl, pyridyl, pyrimidinyl and thienyl, which furanyl, pyridazinyl, pyridyl, pyrimidinyl and thienyl are unsubstituted or substituted with 1 or 2 substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-C6haloalkyl, C3-C6halocycloalkyl, -Ci-C3haloalkyl-C3-C6cycloalkyl, -(Co-C6alkyl)heterocyclyl, halogen, CN, NO2, Ci- Cealkoxy, Ci-Cehaloalkoxy, -S-Ci-Cealkyl,

Cealkyl,

Embodiment 9: The compound according to any one of embodiments 1 to 7, wherein

Ar ¹ is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-C6haloalkyl, C3-C6halocycloalkyl, -Ci- C3haloalkyl-C3-C6cycloalkyl, -(Co-C6alkyl)heterocyclyl, halogen, CN, NO2, Ci-C6alkoxy, Ci- Cehaloalkoxy, -S-Ci-Cealkyl, - CHO, -C(=0)(C ₂ -C ₆ alkoxy) and

Embodiment 10: The compound according to embodiment 8, wherein Ar ¹ is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, Ci- Cehaloalkyl, halogen, Ci-C6alkoxy and Ci-C6haloalkoxy.

Embodiment 1 1 : A compound according to any one of embodiments 1 to 9, wherein Ar ² is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci- Cealkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, Ci-C6haloalkyl, C3-C6halocycloalkyl, -Ci- C3haloalkyl-C3-C6cycloalkyl, C3-C6cycloalkoxy, halogen, cyano, Ci-C6alkoxy, Ci-C6haloalkoxy and -S- Ci-Cealkyl. Embodiment 12: A compound according to any one of embodiments 1 to 9, wherein Ar ² is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci- C4alkyl, Ci-C4haloalkyl, halogen, Ci-C4alkoxy and Ci-C4haloalkoxy. Embodiment 13: A compound according to any one of embodiments 1 to 12, wherein W is NR and R is H.

Embodiment 14: A compound according to any one of embodiments 1 to 13, wherein R ² is selected from H, Ci-C6alkyl and Ci-C6haloalkyl.

Embodiment 15: A compound according to any one of embodiments 1 to 14, wherein R ³ is selected from -C(=0)-(Co-C ₆ -alkyl)(heteroaryl), -C(=0)-(Co-C ₆ -alkyl)(heterocyclyl), -(Co-C ₆ -alkyl)(heteroaryl), - (Co-C6-alkyl)(heterocyclyl), -(Co-C6-alkyl)-0-(heteroaryl) and -(Co-C6-alkyl)-0-(heterocyclyl), which alkyl, heteroaryl and heterocyclyl are unsubstituted or substituted with one to three substituents independently selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, - phenyl and -Si(Ci-C ₆ -alkyl) ₃ .

Embodiment 16: A compound according to any one of embodiments 1 to 14, wherein R ³ is selected from -(Co-C6-alkyl)(heteroaryl) and -(Co-C6-alkyl)(heterocyclyl), which alkyl, heteroaryl and heterocyclyl are unsubstituted or substituted with one to three substituents independently selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy.

Embodiment 17: A compound according to any one of embodiments 1 to 16, wherein Z is a 4- to 7- membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, Ci-C4alkoxy, oxo, hydroxy, - C(=0)OH, phenyl, heteroaryl and heterocyclyl, and wherein each phenyl, heterocyclyl and heteroaryl substituent is unsubstituted or substituted with one or two substituents independently selected from oxo, hydroxy, Ci-C4haloalkyl, Ci-C4haloalkoxy and -C(=0)OH. Embodiment 18: A compound according to any one of embodiments 1 to 16, wherein Z is a 4- to 7- membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, Ci-C4alkoxy, oxo and hydroxy.

Embodiment 19: A compound according to any one of embodiments 1 to 16, wherein Z is a 5- membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, oxo and hydroxy.

Embodiment 20: A compound according to any one of embodiments 1 to 19, wherein J is a 5- or 6- membered heteroaryl, wherein said heteroaryl is unsubstituted or substituted with one to three substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, -(Co-C6-alkyl)C3- ecycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, -(Co-C6-alkyl)C3-8halocycloalkyl, -Ci- Cshaloalkyl-Cs-Cecycloalkyl, -(Co-C ₆ -alkyl)(heterocyclyl), halogen, CN, -Ci-C ₄ alkyl-CN, -C ₃ - Cecycloalkyl-CN, N0 ₂ , Ci-C ₆ alkoxy, Ci-C ₄ haloalkoxy, Ci-C4alkoxy-Ci-C ₄ alkyl S-Ci-Cealkyl, -S(0)-Ci- Cealkyl, -S(=0) ₂ O-Cealk l, -S-Ci-Cehaloalkyl, -S(0)-Ci-C ₆ haloalkyl, -S(=0) ₂ Ci-Cehaloalkyl, -NH(Ci-C ₆ alkyl), -N(C ₂ -C ₆ alkyl)2, -NH(C ₃ -C ₆ cycloalkyl), - N(Ci-C ₆ alkyl)(C3-C ₆ cycloalkyl), CHO, -C(=0)(C2-C ₆ alkoxy),

Cehaloalkoxy),

Embodiment 21 : A compound according to any one of embodiments 1 to 19, wherein J is selected from triazolyl, imidazolyl and pyrazolyl, which triazolyl, imidazolyl and pyrazolyl are unsubstituted or substituted with one or two substituents independently selected from Ci-C6alkyl, C2-C6alkenyl, C2- Cealkynyl, -(Co-6alkyl)C3-8cycloalkyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, -(Co-6alkyl)C3- ehalocycloalkyl and halogen.

Embodiment 22: A compound according to any one of embodiments 1 to 19, wherein J

Embodiment 23: A compound according to any one of embodiments 1 to 19, wherein J is

Embodiment 24: A compound according to any one of embodiments 1 to 19, wherein J is

Embodiment 25: A compound according to any one of embodiments 1 to 19, wherein J is

Embodiment 26: A compound according to any one of embodiments 1 to 25, wherein

Q is selected from

(i)

(iv)

(v)

Embodiment 27: A compound according to any one of embodiments 1 to 25, wherein Q is

Embodiment 28: A compound according to any one of embodiments 1 to 25, wherein Q is

Embodiment 29: A compound according to any one of embodiments 1 to 25, wherein

Q is

Embodiment 30: A compound according to any one of embodiments 1 to 7, wherein

Q is

W is NH;

Y is O or S;

R ² is selected from H, Ci-C6alkyl and Ci-C6haloalkyl;

Ar ¹ is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci-C6alkyl, Ci-C6haloalkyl, halogen, Ci-C6alkoxy and Ci-C6haloalkoxy;

Ar ² is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci-C4alkyl, Ci-C4haloalkyl, halogen, Ci-C4alkoxy and Ci-C4haloalkoxy; or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 31 : A compound according to any one of embodiments 1 to 7, wherein

Q is

Y is O or S;

R ^a is selected from Ci-C6alkyl, Ci-C6haloalkyl, halogen, Ci-C6alkoxy and Ci-C6haloalkoxy;

Ar ² is

R ^b and R ^c are independently selected from H, Ci-C6alkyl and halogen; preferably R ^b is Ci-C6alkyl and R ^c is H, more preferably R ^b is isopropyl and R ^c is H;

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 32: A compound according to any one of embodiments 1 to 7, wherein

Q is

Ar ² is phenyl which is unsubstituted or substituted by one to three substituents independently selected from Ci-C4alkyl, Ci-C4haloalkyl, halogen, Ci-C4alkoxy and Ci-C4haloalkoxy;

Z is a 4- to 7-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, Ci-C4alkoxy, oxo and hydroxy;

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 33: A compound according to any one of embodiments 1 to 7, wherein

Q is

R ^b and R ^c are independently selected from H, Ci-C6alkyl and halogen; preferably R ^b is Ci-C6alkyl and R ^c is H, more preferably R ^b is isopropyl and R ^c is H;

Z is a 5 or 6-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, oxo and hydroxy; or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof. Embodiment 34: A compound according to any one of embodiments 1 to 7, wherein

Q is

Ar ² is

R ^b and R ^c are independently selected from H, Ci-C6alkyl and halogen; preferably R ^b is Ci-C6alkyl and R ^c is H, more preferably R ^b is isopropyl and R ^c is H;

Z is a 5-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, oxo and hydroxy; or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof. Embodiment 35: A compound according to any one of embodiments 1 to 7, wherein

Q is

Ar ² is

R ^b and R ^c are independently selected from H, Ci-C6alkyl and halogen; preferably R ^b is Ci-C6alkyl and R ^c is H, more preferably R ^b is isopropyl and R ^c is H;

Z is a 5 or 6-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, oxo and hydroxy; or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 36: A compound according to any one of embodiments 1 to 7, wherein Q is

R ^b and R ^c are independently selected from H, Ci-C6alkyl and halogen; preferably R ^b is Ci-C6alkyl and R ^c is H, more preferably R ^b is isopropyl and R ^c is H;

Z is a 5-membered heterocyclyl or heteroaryl, which heterocyclyl or heteroaryl is unsubstituted or substituted with one or two substituents independently selected from Ci-C6-alkyl, oxo and hydroxy; or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

Embodiment 37: A compound according to claim 1 , wherein the compound is selected from

1-(2-isopropylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]thiourea (P1.4);

1- (2-isopropylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]urea (P1.3); 3-(2-isopropylphenyl)-N-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]-1 ,3-thiazeti^ 2-imine (P2.1 );

3-(2-isopropylphenyl)-4-methyl-N-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiazol-2-imine (P2.2);

(2Z)-3-(2-isopropylphenyl)-2-[[6-[1-[4-(trifluoromethoxy)phe nyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]imino]thiazolidin-4-one (P2.3);

(2E)-2-(2-isopropylphenyl)imino-3-[6-[1-[4-(trifluorometh oxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiazolidin-4-one (P2.4);

3-(2-isopropylphenyl)-N-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]-1 ,3-thiazeti^

2- imine (P2.1 );

3- (2-isopropylphenyl)-4-methyl-N-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiazol-2-imine (P2.2);

(2Z)-3-(2-isopropylphenyl)-2-[[6-[1-[4-(trifluoromethoxy)phe nyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]imino]thiazolidin-4-one (P2.3);

(2E)-2-(2-isopropylphenyl)imino-3-[6-[1-[4-(trifluoromethoxy )phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiazolidin-4-one (P2.4);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1 -(p-tolyl)-1 ,2,4-triazol-3-yl]-2-quinolyl]thiourea (P1.5); 1-(2,6-dimethylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-2-naphthyl]thiourea (P1.6);

1-(2-isopropylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-2-naphthyl]thiourea (P1.7);

1-(2-isopropylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-2-naphthyl]urea (P1.8);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-2-naphth (P1.9);

1-(2,6-dimethylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]quinazolin-2-yl]thiourea (P1 .10);

1-(2-isopropylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]quinazolin-2-yl]thiourea (P1 .1 1 );

1-(2-isopropylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]quinazolin-2-yl]urea (P1 .12);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1-(p-tolyl)-1 _^ ^ (P1 .13);

1-(2,6-dimethylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]quinoxalin-2-yl]th (P1 .14);

1-(2-isopropylphenyl)-3-[6-[1-(p-to^ (P1 .15);

1-(2-isopropylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]quinoxalin-2-yl]urea (P1 .16);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1-(p-tolyl)-1 _^ ^ (P1.17);

1-(2,6-dimethylphenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-1 ,8-naphthyridin^ (P1 .18);

1-(2-isopropylphenyl)-3-[6-[1 -(p-tolyl)-1 ,2,44riazol-3-yl]-1 ,8-naphthyridin-2-y^ (P1 .19);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-1 ,8-naphthyridin-2-yl]thiourea (P1 .20);

1-(2-chloro-6-methyl-phenyl)-3-[6-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-1 ,8-naphthyridin-2-yl]urea (P1.21 );

1-(2-isopropylphenyl)-3-[3-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-7-quinolyl]thiourea (P1 .22);

1-(2-isopropylphenyl)-3-[2-[1-(p-tolyl)-1 ,2,4-triazol-3-yl]-6-quinolyl]thiourea (P1 .23); and

1-(2-isopropylphenyl)-3-[7-[1 -(p-tolyl)-1 ,2,4-triazol-3-yl]-1 ,8-naphthyridin-3-yl]thiourea (P1 .24);

or an agrochemically acceptable salt, stereoisomer, tautomer, N-oxide thereof.

The term "compounds of the (present) invention" or "a compound of the (present) invention" refers to a compound as defined in any one of embodiment 1 to 37. The compounds according to any one of embodiments 1 to 37 may be prepared according to the following Schemes 1 to 6 or according to methods described in WO2012/109125. The process for preparing compounds of the present invention is carried out in principle by methods known to those skilled in the art. The reagents in Schemes 1-6 are either commercially available or may be prepared according to known methods.

Compounds of formula (1.1 ) may be prepared, as depicted in scheme 1 , by reacting compounds (1 ) with compounds (2), wherein X is O or S, in the presence or in the absence of a base, such as sodium carbonate or triethylamine, DBU (1 ,8-Diazabicyclo[5.4.0]undec-7-ene), DBN (1 ,5- Diazabicyclo[4.3.0]non-5-ene), NaH, NaOMe or NaOtBu, in a suitable solvent or a solvent mixture, such as tetrahydrofuran, DMF, dioxane or acetonitrile. The reaction temperature can preferentially range from room temperature to the boiling point of the reaction mixture.

Scheme 1

(1 ) (2) (1.1 )

wherein Ar ¹ , Y, J, A ¹ , A ² , A ³ , A ⁴ , A ⁵ , A ⁶ , and Ar ² are as described in any one of embodiments 1 to 37.

Compounds (10) may be prepared according to scheme 2. Compounds (3) or their preparation methods are known from the literature (e.g. A. K. Katritstky, A. F. Pozharskii, Handbook of

Heterocyclic Chemistry, 2 ^nd edition, Pergamon, Oxford, 2000). Cyanation to compound (4) may be done under Pd or Cu catalysis, with CuHal or Zn(CN)2 as the CN source. Compounds (4) may be chlorinated to compounds (5), which may be further substituted with a compound of formula

HN(PG )(PG ² ) through a Pd or Cu catalysed reaction. PGi and PG2 are independently selected from H, COOtBu, COOMe, COOEt, SiMe3, allyl. The cyano group may be converted to a 1 ,2,4-triazole compounds (9) through hydrolysis to a compound (7), reaction with DMF-DMA and cyclisation with hydrazine hydrate. Compounds (10) may be obtained by reaction of a compound (9) with Ar -Hal or Ar -B(OH)2 under Cu or Pd catalysis. Pd or Cu catalysis methods and conditions are described in Metal-Catalyzed Cross-Coupling Reactions, 2nd Edition, A. de Meijere, F. Diederich eds, Wiley-VCH, Weinheim, 2004. Hal is halogen, Ar ¹ , A ¹ , A ² , A ³ , A ⁴ , A ⁵ and A ⁶ are as described above.

Scheme 2:

wherein A ¹ , A ² , A ³ , A ⁴ , A ⁵ and A ⁶ are as described in any one of embodiments 1 to 37, Hal is a halogen, particularly chloro or iodo. Pd and PG2 are independently selected from H, COOtBu, COOMe, COOEt, SiMe ₃ , allyl.

Compounds (1 ) may also be prepared according to scheme 3. Compounds (1 1 ) or their preparation methods are known from the literature (e.g. A. K. Katritstky, A. F. Pozharskii, Handbook of

Heterocyclic Chemistry, 2 ^nd edition, Pergamon, Oxford, 2000). They can be chlorinated to a compound (12), which reacts under Suzuki conditions with a compound of formula Ar -J-B(OH)2 or Ar -J-B(Pin) to a compound of formula (13). Alternatively, a compound of formula (14) may be prepared from a compound (12) through metalation (nBuli, or iPrMgCI or iPrMgCI.LiCI) and reaction with a borate (e.g. B(OiPr)3). Compounds (14) may react with a compound of formula Ar -J-Hal to a compound (13) in a Suzuki reaction. Compound (13) can be transformed to a compound of formula (15) by reacting with a compound of formula HN(PGi)(PG2) under Cu or Pd catalysis. Conditions for the Suzuki reactions and Pd or Cu catalysed reactions are described in Metal-Catalyzed Cross- Coupling Reactions, 2nd Edition, A. de Meijere, F. Diederich eds, Wiley-VCH, Weinheim, 2004.

Scheme 3:

(1 ) (15) wherein Hal is halogen, J, Ar ¹ , A ¹ , A ² , A ³ , A ⁴ , A ⁵ , and A ⁶ are as described in any one of embodiments 1 to 37. PG and PG ² are independently H, COOtBu, COOMe, COOEt, SiMe ₃ , allyl.

Alternatively, compounds (1 ) may be prepared as depicted in scheme 4, by modifying the reaction sequence described in scheme 3. Hal is halogen, J, Ar ¹ , A ¹ , A ² , A ³ , A ⁴ , A ⁵ , and A ⁶ are as described in any one of embodiments 1 to 37. PGi and PG2 are independently H, COOtBu, COOMe, COOEt, SiMe ₃ , allyl.

Scheme 4:

Compounds of formula (1.3), (I.4), (1.5) and (1.6) can be prepared from a compound of formula (I.2) according to scheme 5 in the presence or in the absence of a base such as Na2C03, NEt.3, DBU, DBN, MeONa, tBuONa. LG is a leaving group e.g. CI, Br, I, OMes, OTos, OMe. J, Ar ¹ , A ¹ , A ² , A ³ , A ⁴ , A ⁵ , A ⁶ , Ar ² and R ³ are as described in any one of embodiments 1 to 37. R ⁵ is a -(Ci-C4alkyl)- which may be unsubstituted or substituted with a substituent as described for Z in embodiments 17-19. In each reaction, a mixture of compounds of formula (1.3) and (I.4) or (1.5) and (1.6) can be formed and can be separated by crystallization or chromatography methods.

Alternatively, compounds (1.7) and (1.8) may be prepared by reacting a compound (I.2) with chloroacetone or bromoacetone in the presence of a base such as Na2C03, NEt.3, DBU, DBN, MeONa, tBuONa. J, Ar\ A ¹ , A ² , A ³ , A ⁴ , A ⁵ , A ⁶ and Ar ² are as described above, Hal' is CI or Br. A mixture of compounds of formula (1.7) and (1.8) can be formed and can be separated by crystallization or chromatography methods.

Compounds of formula (Γ.1 ) may be prepared, as depicted in scheme 7, by reacting compounds (1 ') with compounds (2), wherein X is O or S, in the presence or in the absence of a base, such as sodium carbonate or triethylamine, DBU (1 ,8-diazabicyclo[5.4.0]undec-7-ene), DBN (1 ,5- diazabicyclo[4.3.0]non-5-ene), NaH, NaOMe or NaOtBu, in a suitable solvent or a solvent mixture, such as tetrahydrofuran, DMF, dioxane or acetonitrile. The reaction temperature can preferentially range from room temperature to the boiling point of the reaction mixture.

Scheme 7:

(2) (IM )

Compounds (1 ') may be prepared according to scheme 8. Compounds (1 1 ') or their preparation methods are known from the literature (e.g. A. K. Katritstky, A. F. Pozharskii, Handbook of

Heterocyclic Chemistry, 2 ^nd edition, Pergamon, Oxford, 2000). They can be chlorinated to a compound (12'), which reacts under Suzuki conditions with a compound of formula Ar -J-B(OH)2 or Ar -J-B(Pin) to a compound of formula (13'). Alternatively, a compound of formula (14') may be prepared from a compound (12') through metalation (nBuli, or iPrMgCI or iPrMgCI.LiCI) and reaction with a borate (e.g. B(OiPr)3). Compounds (14') may react with a compound of formula Ar -J-Hal to a compound (13') in a Suzuki reaction. Compound (13') can be transformed to a compound of formula (15') by reacting with a compound of formula HN(PGi)(PG2) under Cu or Pd catalysis. Conditions for the Suzuki reactions and Pd or Cu catalysed reactions are described in Metal-Catalyzed Cross- Coupling Reactions, 2nd Edition, A. de Meijere, F. Diederich eds, Wiley-VCH, Weinheim, 2004.

Scheme 8:

"Suzuki"

(11 ') ') (13')

(1 ') (15') Alternatively compounds (1 ') may be prepared according to scheme 9. Compounds (16') or their preparation methods are known from the literature (e.g. A. K. Katritstky, A. F. Pozharskii, Handbook of Heterocyclic Chemistry, 2 ^nd edition, Pergamon, Oxford, 2000). They can react under Suzuki conditions with a compound of formula Ar -J-B(OH)2 or Ar -J-B(Pin) to a compound of formula (1 '). Alternatively, a compound of formula (17') may be prepared from a compound (16') through metalation (nBuli, or iPrMgCI or iPrMgCI.LiCI) and reaction with a borate (e.g. B(OiPr)3). Compounds (17') may react with a compound of formula Ar -J-Hal to a compound (1 ') in a Suzuki reaction.

Conditions for the Suzuki reactions and Pd or Cu catalysed reactions are described in Metal- Catalyzed Cross-Coupling Reactions, 2nd Edition, A. de Meijere, F. Diederich eds, Wiley-VCH, Weinheim, 2004.

Scheme 9:

Compounds of formula ( .3), ( .4), (Γ.5) and (Γ.6) can be prepared from a compound of formula (Γ.2) according to scheme 10 in the presence or in the absence of a base such as Na2C03, NEt.3, DBU, DBN, MeONa, tBuONa. LG is a leaving group e.g. CI, Br, I, OMes, OTos, OMe. J, Ar\ A ¹ , A ² , A ³ , A ⁴ , A ⁵ , A ⁶ , Ar ² and R ³ are as described in any one of embodiments 1 to 37. R ⁵ is a -(Ci-C4alkyl)- which may be unsubstituted or substituted with a substituent as described for Z in embodiments 17-19. In each reaction, a mixture of compounds of formula (Γ.3) and (Γ.4) or (Γ.5) and (Γ.6) can be formed and can be separated by crystallization or chromatography methods.

Scheme 10:

Depending on the procedure or the reaction conditions, the compounds of the invention which have salt-forming properties can be obtained in free form or in the form of salts.

The compounds according to any one of embodiments 1 to 37 and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the

stereoisomers which are possible or as a mixture of these, for example in the form of pure stereoisomers, such as antipodes and/or diastereomers, or as stereoisomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure stereoisomers and also to all stereoisomer mixtures which are possible and is to be understood in each case in this sense hereinabove and herein below, even when stereochemical details are not mentioned specifically in each case.

Diastereomer mixtures or racemate mixtures of compounds according to any one of embodiments 1 to 37, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography. Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid

chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be resolved by the action of suitable agents, for example basic agents.

Pure diastereomers or enantiomers can be obtained not only by separating suitable stereoisomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.

N-oxides can be prepared by reacting a compound according to any one of embodiments 1 to 37 with a suitable oxidizing agent, for example the hhCh/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. Such oxidations are known from the literature, for example from J. Med. Chem. 1989, 32, 2561 or WO 2000/15615.

The compounds according to any one of embodiments 1 to 37 and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.

The compounds according to any one of embodiments 1 to 37 are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants.

Compounds according to any one of embodiments 1 to 37 may act against all or only individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the compounds can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate, a good activity corresponding to a destruction rate (mortality) of at least 50 to 60%.

Examples of the abovementioned animal pests are:

from the order Acarina, for example, Acalitus spp, Aculus spp, Acaricalus spp, Aceria spp, Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp, Eotetranychus spp, Eriophyes spp., Hemitarsonemus spp, Hyalomma spp., Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polypha- gotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp.,

Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.; from the order Anoplura, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.;

from the order Coleoptera, for example, Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis,

Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa

decemLineata, Lissorhoptrus spp., Liogenys spp, Maecolaspis spp, Maladera castanea, Megascelis spp, Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp, Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp, Sphenophorus spp, Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp.;

from the order Diptera, for example, Aedes spp., Anopheles spp, Antherigona soccata,Bactrocea oleae, Bibio hortulanus, Bradysia spp, Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp, Drosophila melanogaster, Fannia spp.,

Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomy- za spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp, Rivelia quadrifasciata, Scatella spp, Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.;

from the order Hemiptera, for example, Acanthocoris scabrator, Acrosternum spp, Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp, Cimex spp., Clavigralla

tomentosicollis, Creontiades spp, Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp, Euchistus spp., Eurydema pulchrum, Eurygaster spp., Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp, Margarodes spp, Murgantia histrionic, Neomegalotomus spp,

Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp. , Thyanta spp , Triatoma spp., and Vatiga illudens;

from the order homoptera, for example, Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aonidiella auranti, Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp, Cofana spectra, Cryptomyzus spp, Cicadulina spp, Coccus hesperidum, Dalbulus maidis, Dialeurodes spp, Diaphorina citri, Diuraphis noxia, Dysaphis spp, Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp, Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis erysimi, Lyogenys maidis, Macrosiphum spp., Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza erytreae , Unaspis citri, Zygina flammigera, and Zyginidia scutellaris;

from the order Hymenoptera, for example, Acromyrmex, Arge spp, Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp, Slenopsis invicta, Solenopsis spp. and Vespa spp.;

from the order Isoptera, for example, Coptotermes spp, Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp.; Solenopsis geminate; from the order Lepidoptera, for example, Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp,

Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella,

Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp, Crocidolomia binotalis, Cryptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp, Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Grapholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp, Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp, Noctua spp, Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypiela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp, Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusiani, Tuta absoluta, and Yponomeuta spp.;

from the order Mallophaga, for example, Damalinea spp. and Trichodectes spp.;

from the order Orthoptera, for example, Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp. , Scapteriscus spp, and

Schistocerca spp.;

from the order Psocoptera, for example, Liposcelis spp.;

from the order Siphonaptera, for example, Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis;

from the order Thysanoptera, for example, Calliothrips phaseoli, Frankliniella spp., Heliothrips spp, Hercinothrips spp., Parthenothrips spp, Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp; and/or from the order Thysanura, for example, Lepisma saccharina.

Examples of soil-inhabiting pests, which can damage a crop in the early stages of plant development, are:

from the order Lepidoptera, for example, Acleris spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Autographa spp., Busseola fusca, Cadra cautella, Chilo spp., Crocidolomia binotalis, Diatraea spp., Diparopsis castanea, Elasmopalpus spp., Heliothis spp., Mamestra brassicae, Phthorimaea operculella, Plutella xylostella, Scirpophaga spp., Sesamia spp., Spodoptera spp. and Tortrix spp.;

from the order Coleoptera, for example, Agriotes spp., Anthonomus spp., Atomaria linearis,

Chaetocnema tibialis, Conotrachelus spp., Cosmopolites spp., Curculio spp., Dermestes spp., Diabrotica spp., Dilopoderus spp., Epilachna spp., Eremnus spp., Heteronychus spp., Lissorhoptrus spp., Melolontha spp., Orycaephilus spp., Otiorhynchus spp., Phlyctinus spp., Popillia spp., Psylliodes spp., Rhizopertha spp., Scarabeidae, Sitotroga spp., Somaticus spp., Tanymecus spp., Tenebrio spp., Tribolium spp., Trogoderma spp. and Zabrus spp.;

from the order Orthoptera, for example, Gryllotalpa spp.;

from the order Isoptera, for example, Reticulitermes spp.;

from the order Psocoptera, for example, Liposcelis spp.;

from the order Anoplura, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.;

from the order Homoptera, for example, Eriosoma larigerum;

from the order Hymenoptera, for example, Acromyrmex, Atta spp., Cephus spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Solenopsis spp. and Vespa spp.;

from the order Diptera, for example, Tipula spp.;

crucifer flea beetles (Phyllotreta spp.), root maggots (Delia spp.), cabbage seedpod weevil

(Ceutorhynchus spp.) and aphids.

The compounds according to any one of embodiments 1 to 37 may be useful for the control of nematodes. Thus, in one embodiment, the invention also relates to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes,

Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes,

Aphelenchoides species; Sting nematodes, Eelonolaimus longicaudatus and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species; Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species; Awl nematodes, Dolichodorus species; Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species; Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species; Hirshmanniella species; Lance nematodes, Hoploaimus species; false rootknot nematodes, Nacobbus species; Needle nematodes, Longidorus elongatus and other Longidorus species; Pin nematodes, Pratylenchus species; Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species; Citrus nematodes, Tylenchulus species; Dagger nematodes, Xiphinema species; and other plant parasitic nematode species, such as Subanguina., spp

Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp.. In particular, the nematode species Meloidogyne spp., Heterodera spp., Rotylenchus spp. and Pratylenchus spp. can be controlled by the compounds according to any one of embodiment 1 to 37. The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.

Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family, latex plants and ornamentals.

The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.

Further areas of use of the compositions according to the invention are the protection of stored goods and store ambients and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type. Thus, in one embodiment 38, there is also provided a method for controlling pests (such as mosquitoes and other disease vectors). In embodiment 39, the method for controlling pests comprises applying the compositions according to any one of embodiments 1 to 37 to the pests or their environment, to their locus, for example the soil or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In an embodiment 40, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 2003/034823, US 5631072, WO 2005/64072, WO2006/128870, EP 1724392, WO20051 13886 or WO 2007/090739.

In embodiment 41 , the invention therefore also relates to pesticidal compositions such as emulsifiable concentrates, suspension concentrates, microemulsions, oil dispersibles, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, soluble powders, dispersible powders, wettable powders, dusts, granules or encapsulations in polymeric substances, which comprise - at least - one compound according to any one of embodiments 1 to 37 and which are to be selected to suit the intended aims and the prevailing circumstances.

Thus, in embodiment 42, the invention therefore relates to a pesticidal composition, which comprises at least one compound according to any one of embodiments 1 to 37 as active ingredient and at least one auxiliary.

Hence, in embodiment 43, the method for controlling such pests comprises applying a pesticidally effective amount of a composition according to embodiment 42 to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment 44, it is contemplated to apply a composition according to embodiment 42 for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

In these compositions, the active ingredient is employed in pure form, a solid active ingredient for example in a specific particle size, or, preferably, together with - at least - one of the auxiliaries conventionally used in the art of formulation, such as extenders, for example solvents or solid carriers, or such as surface-active compounds (surfactants). Examples of suitable solvents are:

unhydrogenated or partially hydrogenated aromatic hydrocarbons, preferably the fractions Cs to C12 of alkylbenzenes, such as xylene mixtures, alkylated naphthalenes or tetrahydronaphthalene, aliphatic or cycloaliphatic hydrocarbons, such as paraffins or cyclohexane, alcohols such as ethanol, propanol or butanol, glycols and their ethers and esters such as propylene glycol, dipropylene glycol ether, ethylene glycol or ethylene glycol monomethyl ether or ethylene glycol monoethyl ether, ketones, such as cyclohexanone, isophorone or diacetone alcohol, strongly polar solvents, such as N- methylpyrrolid-2-one, dimethyl sulfoxide or Ν,Ν-dimethylformamide, water, unepoxidized or epoxidized vegetable oils, such as unexpodized or epoxidized rapeseed, castor, coconut or soya oil, and silicone oils.

Solid carriers which are used for example for dusts and dispersible powders are, as a rule, ground natural minerals such as calcite, talc, kaolin, montmorillonite or attapulgite. To improve the physical properties, it is also possible to add highly disperse silicas or highly disperse absorbtive polymers. Suitable adsorptive carriers for granules are porous types, such as pumice, brick grit, sepiolite or bentonite, and suitable non-sorptive carrier materials are calcite or sand. In addition, a large number of granulated materials of inorganic or organic nature can be used, in particular dolomite or comminuted plant residues.

Suitable surface-active compounds are, depending on the type of the active ingredient to be formulated, non-ionic, cationic and/or anionic surfactants or surfactant mixtures which have good emulsifying, dispersing and wetting properties. The surfactants mentioned below are only to be considered as examples; a large number of further surfactants which are conventionally used in the art of formulation and suitable according to the invention are described in the relevant literature.

Suitable non-ionic surfactants are, especially, polyglycol ether derivatives of aliphatic or cycloaliphatic alcohols, of saturated or unsaturated fatty acids or of alkyl phenols which may contain approximately 3 to approximately 30 glycol ether groups and approximately 8 to approximately 20 carbon atoms in the (cyclo)aliphatic hydrocarbon radical or approximately 6 to approximately 18 carbon atoms in the alkyl moiety of the alkyl phenols. Also suitable are water-soluble polyethylene oxide adducts with polypropylene glycol, ethylenediaminopolypropylene glycol or alkyl polypropylene glycol having 1 to approximately 10 carbon atoms in the alkyl chain and approximately 20 to approximately 250 ethylene glycol ether groups and approximately 10 to approximately 100 propylene glycol ether groups.

Normally, the abovementioned compounds contain 1 to approximately 5 ethylene glycol units per propylene glycol unit. Examples which may be mentioned are nonylphenoxypolyethoxyethanol, castor oil polyglycol ether, polypropylene glycol/polyethylene oxide adducts,

tributylphenoxypolyethoxyethanol, polyethylene glycol or octylphenoxypolyethoxyethanol. Also suitable are fatty acid esters of polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate. The cationic surfactants are, especially, quarternary ammonium salts which generally have at least one alkyl radical of approximately 8 to approximately 22 C atoms as substituents and as further substituents (unhalogenated or halogenated) lower alkyl or hydroxyalkyl or benzyl radicals. The salts are preferably in the form of halides, methylsulfates or ethylsulfates. Examples are

stearyltrimethylammonium chloride and benzylbis(2-chloroethyl)ethylammonium bromide.

Examples of suitable anionic surfactants are water-soluble soaps or water-soluble synthetic surface- active compounds. Examples of suitable soaps are the alkali, alkaline earth or (unsubstituted or substituted) ammonium salts of fatty acids having approximately 10 to approximately 22 C atoms, such as the sodium or potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which are obtainable for example from coconut or tall oil; mention must also be made of the fatty acid methyl taurates. However, synthetic surfactants are used more frequently, in particular fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylaryl sulfonates. As a rule, the fatty sulfonates and fatty sulfates are present as alkali, alkaline earth or (substituted or unsubstituted) ammonium salts and they generally have an alkyl radical of approximately 8 to approximately 22 C atoms, alkyl also to be understood as including the alkyl moiety of acyl radicals; examples which may be mentioned are the sodium or calcium salts of lignosulfonic acid, of the dodecylsulfuric ester or of a fatty alcohol sulfate mixture prepared from natural fatty acids. This group also includes the salts of the sulfuric esters and sulfonic acids of fatty alcohol/ethylene oxide adducts. The sulfonated

benzimidazole derivatives preferably contain 2 sulfonyl groups and a fatty acid radical of

approximately 8 to approximately 22 C atoms. Examples of alkylarylsulfonates are the sodium, calcium or triethanolammonium salts of decylbenzenesulfonic acid, of dibutylnaphthalenesulfonic acid or of a naphthalenesulfonic acid/formaldehyde condensate. Also possible are, furthermore, suitable phosphates, such as salts of the phosphoric ester of a p-nonylphenol/(4-14)ethylene oxide adduct, or phospholipids.

As a rule, the compositions comprise 0.1 to 99%, especially 0.1 to 95%, of active ingredient and 1 to 99.9%, especially 5 to 99.9%, of at least one solid or liquid adjuvant, it being possible as a rule for 0 to 25%, especially 0.1 to 20%, of the composition to be surfactants(% in each case meaning percent by weight). Whereas concentrated compositions tend to be preferred for commercial goods, the end consumer as a rule uses dilute compositions which have substantially lower concentrations of active ingredient.

Typically, a pre-mix formulation for foliar application comprises 0.1 to 99.9 %, especially 1 to 95 %, of the desired ingredients, and 99.9 to 0.1 %, especially 99 to 5 %, of a solid or liquid adjuvant

(including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 %, especially 0.5 to 40 %, based on the pre-mix formulation.

Normally, a tank-mix formulation for seed treatment application comprises 0.25 to 80%, especially 1 to 75 %, of the desired ingredients, and 99.75 to 20 %, especially 99 to 25 %, of a solid or liquid auxiliaries (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 40 %, especially 0.5 to 30 %, based on the tank-mix formulation.

Typically, a pre-mix formulation for seed treatment application comprises 0.5 to 99.9 %, especially 1 to 95 %, of the desired ingredients, and 99.5 to 0.1 %, especially 99 to 5 %, of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 %, especially 0.5 to 40 %, based on the pre-mix formulation.

Whereas commercial products will preferably be formulated as concentrates (e.g., pre-mix composition (formulation)), the end user will normally employ dilute formulations (e.g., tank mix composition).

Preferred seed treatment pre-mix formulations are aqueous suspension concentrates. The formulation can be applied to the seeds using conventional treating techniques and machines, such as fluidized bed techniques, the roller mill method, rotostatic seed treaters, and drum coaters. Other methods, such as spouted beds may also be useful. The seeds may be presized before coating. After coating, the seeds are typically dried and then transferred to a sizing machine for sizing. Such procedures are known in the art. In general, the pre-mix compositions of the invention contain 0.5 to 99.9 especially 1 to 95, advantageously 1 to 50 %, by mass of the desired ingredients, and 99.5 to 0.1 , especially 99 to 5 %, by mass of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries (or adjuvant) can be a surfactant in an amount of 0 to 50, especially 0.5 to 40 %, by mass based on the mass of the pre-mix formulation.

Examples of foliar formulation types for pre-mix compositions are:

GR: Granules

WP: wettable powders

WG: water dispersable granules (powders)

SG: water soluble granules

SL: soluble concentrates

EC: emulsifiable concentrate

EW: emulsions, oil in water

ME: micro-emulsion

SC: aqueous suspension concentrate

CS: aqueous capsule suspension

OD: oil-based suspension concentrate, and

SE: aqueous suspo-emulsion.

Whereas, examples of seed treatment formulation types for pre-mix compositions are:

WS: wettable powders for seed treatment slurry

LS: solution for seed treatment

ES: emulsions for seed treatment

FS: suspension concentrate for seed treatment

WG: water dispersible granules, and CS: aqueous capsule suspension.

Examples of formulation types suitable for tank-mix compositions are solutions, dilute emulsions, suspensions, or a mixture thereof, and dusts.

Preferred compositions are composed in particular as follows (% = percent by weight):

Emulsifiable concentrates:

active ingredient: 1 to 95%, preferably 5 to 20%

surfactant: 1 to 30%, preferably 10 to 20 %

solvent: 5 to 98%, preferably 70 to 85%

Dusts:

active ingredient: 0.1 to 10%, preferably 0.1 to 1 %

solid carrier: 99.9 to 90%, preferably 99.9 to 99% Suspension concentrates:

active ingredient: 5 to 75%, preferably 10 to 50%

water: 94 to 24%, preferably 88 to 30%

surfactant: 1 to 40%, preferably 2 to 30%

Wettable powders:

active ingredient: 0.5 to 90%, preferably 1 to 80%

surfactant: 0.5 to 20%, preferably 1 to 15%

solid carrier: 5 to 99%, preferably 15 to 98% Granulates:

active ingredient: 0.5 to 30%, preferably 3 to 15%

solid carrier: 99.5 to 70%, preferably 97 to 85%

The activity of compositions comprising compounds according to the invention can be broadened considerably, and adapted to prevailing circumstances, by including other active substances. The active substances can be of chemical or biological in type, and in the case of biological could be further modified from the biological species derived in nature. Active substances include substances that control, repel or attract pests that damage or harm useful plants in general, but also substances that improve the growth of a useful plant, such as plant growth regulators, and substances that improve the performance of the active substance, such as synergists. Examples are insecticides, acaricides, nematicides, molluscicides, aligicides, virusicides, rodenticide, bactericides, fungicides, chemosterilants, anthelmintics. Examples of a biological active substance include baculovirus, plant extract, and bacteria. The mixtures of the compounds according to any one of embodiments 1 to 37 with other active substances may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages, or better behaviour relating to production, for example grinding or mixing, storage or use.

Individual active substances can occur in more than one group or class, and at more than one place within a group or class: information about the active substances, their spectrum, sources and classifications can be found from Compendium of Pesticide Common Names (see

http://www.alanwood.net pesticides/index.html) or from the Pesticide Manual created by the British Crop Production Counci (see http://bcpcdata.com/pesticide-manual.html).

Preferred mixtures are indicated below where a compound according to any one of embodiment 1 to 37 is indicated as "I".

Compositions comprising an adjuvant include I + compounds selected from the group of substances consisting of petroleum oils;

Compositions comprising an acaricide include I + 1 , 1-bis(4-chlorophenyl)-2-ethoxyethanol, I + 2,4- dichlorophenyl benzenesulfonate, I + 2-fluoro-N-methyl-N-1-naphthylacetamide, I + 4-chlorophenyl phenyl sulfone, I + abamectin, I + acequinocyl, I + acetoprole, I + acrinathrin, I + aldicarb, I + aldoxycarb, I + alpha-cypermethrin, I + amidithion, I + amidoflumet, I + amidothioate, I + amiton, I + amiton hydrogen oxalate, I + amitraz, I + aramite, I + arsenous oxide, I + AVI 382, I + AZ 60541 , I + azinphos-ethyl, I + azinphos-methyl, I + azobenzene, I + azocyclotin, I + azothoate, I + benomyl, I + benoxafos, I + benzoximate, I + benzyl benzoate, I + bifenazate, I + bifenthrin, I + binapacryl, I + brofenvalerate, I + bromocyclen, I + bromophos, I + bromophos-ethyl, I + bromopropylate, I + buprofezin, I + butocarboxim, I + butoxycarboxim, I + butylpyridaben, I + calcium polysulfide, I + camphechlor, I + carbanolate, I + carbaryl, I + carbofuran, I + carbophenothion, I + CGA 50'439, I + chinomethionat, I + chlorbenside, I + chlordimeform, I + chlordimeform hydrochloride, I + chlorfenapyr, I + chlorfenethol, I + chlorfenson, I + chlorfensulfide, I + chlorfenvinphos, I + chlorobenzilate, I + chloromebuform, I + chloromethiuron, I + chloropropylate, I + chlorpyrifos, I + chlorpyrifos-methyl, I + chlorthiophos, I + cinerin I, I + cinerin II, I + cinerins, I + clofentezine, I + closantel, I + coumaphos, I + crotamiton, I + crotoxyphos, I + cufraneb, I + cyanthoate, I + cyflumetofen, I + cyhalothrin, I + cyhexatin, I + cypermethrin, I + DCPM, I + DDT, I + demephion, I + demephion-O, I + demephion-S, I + demeton, I + demeton-methyl, I + demeton-O, I + demeton-O-methyl, I + demeton-S, I + demeton- S-methyl, I + demeton-S-methylsulfon, I + diafenthiuron, I + dialifos, I + diazinon, I + dichlofluanid, I + dichlorvos, I + dicliphos, I + dicofol, I + dicrotophos, I + dienochlor, I + dimefox, I + dimethoate, I + dinactin , I + dinex, I + dinex-diclexine, I + dinobuton, I + dinocap, I + dinocap-4, I + dinocap-6, I + dinocton, I + dinopenton, I + dinosulfon, I + dinoterbon, I + dioxathion, I + diphenyl sulfone, I + disulfiram, I + disulfoton, I + DNOC, I + dofenapyn, I + doramectin, I + endosulfan, I + endothion, I + EPN, I + eprinomectin, I + ethion, I + ethoate-methyl, I + etoxazole, I + etrimfos, I + fenazaflor, I + fenazaquin, I + fenbutatin oxide, I + fenothiocarb, I + fenpropathrin, I + fenpyrad, I + fenpyroximate, I + fenson, I + fentrifanil, I + fenvalerate, I + fipronil, I + fluacrypyrim, I + fluazuron, I + flubenzimine, I + flucycloxuron, I + flucythrinate, I + fluenetil, I + flufenoxuron, I + flumethrin, I + fluorbenside, I + fluvalinate, I + FMC 1 137, I + formetanate, I + formetanate hydrochloride, I + formothion, I + formparanate, I + gamma-HCH, I + glyodin, I + halfenprox, I + heptenophos, I + hexadecyl cyclopropanecarboxylate, I + hexythiazox, I + iodomethane, I + isocarbophos, I + isopropyl O- (methoxyaminothiophosphoryl)salicylate, I + ivermectin, I + jasmolin I, I + jasmolin II, I + jodfenphos, I + lindane, I + lufenuron, I + malathion, I + malonoben, I + mecarbam, I + mephosfolan, I + mesulfen, I + methacrifos, I + methamidophos, I + methidathion, I + methiocarb, I + methomyl, I + methyl bromide, I + metolcarb, I + mevinphos, I + mexacarbate, I + milbemectin, I + milbemycin oxime, I + mipafox, I + monocrotophos, I + morphothion, I + moxidectin, I + naled, I + NC-184, I + NC-512, I + nifluridide, I + nikkomycins, I + nitrilacarb, I + nitrilacarb 1 :1 zinc chloride complex, I + NNI-0101 , I + NNI-0250, I + omethoate, I + oxamyl, I + oxydeprofos, I + oxydisulfoton, I + pp'-DDT, I + parathion, I + permethrin, I + petroleum oils, I + phenkapton, I + phenthoate, I + phorate, I + phosalone, I + phosfolan, I + phosmet, I + phosphamidon, I + phoxim, I + pirimiphos-methyl, I + polychloroterpenes, I + polynactins, I + proclonol, I + profenofos, I + promacyl, I + propargite, I + propetamphos, I + propoxur, I + prothidathion, I + prothoate, I + pyrethrin I, I + pyrethrin II, I + pyrethrins, I + pyridaben, I +

pyridaphenthion, I + pyrimidifen, I + pyrimitate, I + quinalphos, I + quintiofos, I + R-1492, I + RA-17, I + rotenone, I + schradan, I + sebufos, I + selamectin, I + SI-0009, I + sophamide, I + spirodiclofen, I + spiromesifen, I + SSI-121 , I + sulfiram, I + sulfluramid, I + sulfotep, I + sulfur, I + SZI-121 , I + tau- fluvalinate, I + tebufenpyrad, I + TEPP, I + terbam, I + tetrachlorvinphos, I + tetradifon, I + tetranactin, I + tetrasul, I + thiafenox, I + thiocarboxime, I + thiofanox, I + thiometon, I + thioquinox, I +

thuringiensin, I + triamiphos, I + triarathene, I + triazophos, I + triazuron, I + trichlorfon, I + trifenofos, I + trinactin, I + vamidothion, I + vaniliprole and I + YI-5302;

Compositions comprising an anthelmintic include I + abamectin, I + crufomate, I + doramectin, I + emamectin, I + emamectin benzoate, I + eprinomectin, I + ivermectin, I + milbemycin oxime, I + moxidectin, I + piperazine, I + selamectin, I + spinosad and I + thiophanate;

Compositions comprising an avicide include I + chloralose, I + endrin, I + fenthion, I + pyridin-4-amine and I + strychnine;

Compositions comprising a biological control agent include I + Adoxophyes orana GV, I +

Agrobacterium radiobacter, I + Amblyseius spp., I + Anagrapha falcifera NPV, I + Anagrus atomus, I + Aphelinus abdominalis, I + Aphidius colemani, I + Aphidoletes aphidimyza, I + Autographa californica NPV, I + Bacillus firmus, I + Bacillus sphaericus Neide, I + Bacillus thuringiensis Berliner, I + Bacillus thuringiensis subsp. aizawai, I + Bacillus thuringiensis subsp. israelensis, I + Bacillus thuringiensis subsp. japonensis, I + Bacillus thuringiensis subsp. kurstaki, I + Bacillus thuringiensis subsp.

tenebrionis, I + Beauveria bassiana, I + Beauveria brongniartii, I + Chrysoperla carnea, I +

Cryptolaemus montrouzieri, I + Cydia pomonella GV, I + Dacnusa sibirica, I + Diglyphus isaea, I + Encarsia formosa, I + Eretmocerus eremicus, I + Helicoverpa zea NPV, I + Heterorhabditis bacteriophora and H. megidis, I + Hippodamia convergens, I + Leptomastix dactylopii, I + Macrolophus caliginosus, I + Mamestra brassicae NPV, I + Metaphycus helvolus, I + Metarhizium anisopliae var. acridum, I + Metarhizium anisopliae var. anisopliae, I + Neodiprion sertifer NPV and N. lecontei NPV, I + Orius spp., I + Paecilomyces fumosoroseus, I + Phytoseiulus persimilis, I +

Spodoptera exigua multicapsid nuclear polyhedrosis virus, I + Steinernema bibionis, I + Steinernema carpocapsae, I + Steinernema feltiae, I + Steinernema glaseri, I + Steinernema riobrave, I +

Steinernema riobravis, I + Steinernema scapterisci, I + Steinernema spp., I + Trichogramma spp., I + Typhlodromus occidentalis and I + Verticillium lecanii;

Compositions comprising a soil sterilant include I + iodomethane and methyl bromide;

Compositions comprising a chemosterilant include I + apholate, I + bisazir, I + busulfan, I + diflubenzuron, I + dimatif, I + hemel, I + hempa, I + metepa, I + methiotepa, I + methyl apholate, I + morzid, I + penfluron, I + tepa, I + thiohempa, I + thiotepa, I + tretamine and I + uredepa;

Compositions comprising an insect pheromone include I + (E)-dec-5-en-1-yl acetate with (E)-dec-5- en-1-ol, I + (E)-tridec-4-en-1-yl acetate, I + (E)-6-methylhept-2-en-4-ol, I + (E,Z)-tetradeca-4, 10-dien- 1-yl acetate, I + (Z)-dodec-7-en-1-yl acetate, I + (Z)-hexadec-l 1-enal, I + (Z)-hexadec-l 1-en-1-yl acetate, I + (Z)-hexadec-13-en-1 1-yn-1-yl acetate, I + (Z)-icos-13-en-10-one, I + (Z)-tetradec-7-en-1- al, I + (Z)-tetradec-9-en-1-ol, I + (Z)-tetradec-9-en-1-yl acetate, I + (7E,9Z)-dodeca-7,9-dien-1-yl acetate, I + (9Z, 1 1 E)-tetradeca-9,1 1-dien-1 -yl acetate, I + (9Z,12E)-tetradeca-9,12-dien-1-yl acetate, I + 14-methyloctadec-1-ene, I + 4-methylnonan-5-ol with 4-methylnonan-5-one, I + alpha-multistriatin, I + brevicomin, I + codlelure, I + codlemone, I + cuelure, I + disparlure, I + dodec-8-en-1-yl acetate, I + dodec-9-en-1-yl acetate, I + dodeca-8, I + 10-dien-1-yl acetate, I + dominicalure, I + ethyl 4- methyloctanoate, I + eugenol, I + frontalin, I + gossyplure, I + grandlure, I + grandlure I, I + grandlure II, I + grandlure III, I + grandlure IV, I + hexalure, I + ipsdienol, I + ipsenol, I + japonilure, I + lineatin, I + litlure, I + looplure, I + medlure, I + megatomoic acid, I + methyl eugenol, I + muscalure, I + octadeca-2, 13-dien-1-yl acetate, I + octadeca-3,13-dien-1-yl acetate, I + orfralure, I + oryctalure, I + ostramone, I + siglure, I + sordidin, I + sulcatol, I + tetradec-1 1-en-1-yl acetate, I + trimedlure, I + trimedlure A, I + trimedlure B1 , I + trimedlure B2, I + trimedlure C and I + trunc-call;

Compositions comprising an insect repellent include I + 2-(octylthio)ethanol, I + butopyronoxyl, I + butoxy(polypropylene glycol), I + dibutyl adipate, I + dibutyl phthalate, I + dibutyl succinate, I + diethyltoluamide, I + dimethyl carbate, I + dimethyl phthalate, I + ethyl hexanediol, I + hexamide, I + methoquin-butyl, I + methylneodecanamide, I + oxamate and I + picaridin;

Compositions comprising an insecticide include I + 1-dichloro-1-nitroethane, I + 1 ,1-dichloro-2,2-bis(4- ethylphenyl)ethane , I +, I + 1 ,2-dichloropropane, I + 1 ,2-dichloropropane with 1 ,3-dichloropropene, I + 1-bromo-2-chloroethane, I + 2,2,2-trichloro-1 -(3,4-dichlorophenyl)ethyl acetate, I + 2,2-dichlorovinyl 2- ethylsulfinylethyl methyl phosphate, I + 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate, I + 2-(2- butoxyethoxy)ethyl thiocyanate, I + 2-(4,5-dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate, I + 2- (4-chloro-3,5-xylyloxy)ethanol, I + 2-chlorovinyl diethyl phosphate, I + 2-imidazolidone, I + 2- isovalerylindan-1 ,3-dione, I + 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate, I + 2- thiocyanatoethyl laurate, I + 3-bromo-1-chloroprop-1 -ene, I + 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate, I + 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate, I + 5,5-dimethyl-3- oxocyclohex-1-enyl dimethylcarbamate, I + abamectin, I + acephate, I + acetamiprid, I + acethion, I + acetoprole, I + acrinathrin, I + acrylonitrile, I + alanycarb, I + aldicarb, I + aldoxycarb, I + aldrin, I + allethrin, I + allosamidin, I + allyxycarb, I + alpha-cypermethrin, I + alpha-ecdysone, I + aluminium phosphide, I + amidithion, I + amidothioate, I + aminocarb, I + amiton, I + amiton hydrogen oxalate, I + amitraz, I + anabasine, I + athidathion, I + AVI 382, I + AZ 60541 , I + azadirachtin, I + azamethiphos, I + azinphos-ethyl, I + azinphos-methyl, I + azothoate, I + Bacillus thuringiensis delta endotoxins, I + barium hexafluorosilicate, I + barium polysulfide, I + barthrin, I + Bayer 22/190, I + Bayer 22408, I + bendiocarb, I + benfuracarb, I + bensultap, I + beta-cyfluthrin, I + beta-cypermethrin, I + bifenthrin, I + bioallethrin, I + bioallethrin S-cyclopentenyl isomer, I + bioethanomethrin, I + biopermethrin, I + bioresmethrin, I + bis(2-chloroethyl) ether, I + bistrifluron, I + borax, I + brofenvalerate, I +

bromfenvinfos, I + bromocyclen, I + bromo-DDT, I + bromophos, I + bromophos-ethyl, I + bufencarb, I + buprofezin, I + butacarb, I + butathiofos, I + butocarboxim, I + butonate, I + butoxycarboxim, I + butylpyridaben, I + cadusafos, I + calcium arsenate, I + calcium cyanide, I + calcium polysulfide, I + camphechlor, I + carbanolate, I + carbaryl, I + carbofuran, I + carbon disulfide, I + carbon

tetrachloride, I + carbophenothion, I + carbosulfan, I + cartap, I + cartap hydrochloride, I + cevadine, I + chlorbicyclen, I + chlordane, I + chlordecone, I + chlordimeform, I + chlordimeform hydrochloride, I + chlorethoxyfos, I + chlorfenapyr, I + chlorfenvinphos, I + chlorfluazuron, I + chlormephos, I + chloroform, I + chloropicrin, I + chlorphoxim, I + chlorprazophos, I + chlorpyrifos, I + chlorpyrifos- methyl, I + chlorthiophos, I + chromafenozide, I + cinerin I, I + cinerin II, I + cinerins, I + cis-resmethrin, I + cismethrin, I + clocythrin, I + cloethocarb, I + closantel, I + clothianidin, I + copper acetoarsenite, I + copper arsenate, I + copper oleate, I + coumaphos, I + coumithoate, I + crotamiton, I + crotoxyphos, I + crufomate, I + cryolite, I + CS 708, I + cyanofenphos, I + cyanophos, I + cyanthoate, I + cyclethrin, I + cycloprothrin, I + cyfluthrin, I + cyhalothrin, I + cypermethrin, I + cyphenothrin, I + cyromazine, I + cythioate, I + d-limonene, I + d-tetramethrin, I + DAEP, I + dazomet, I + DDT, I + decarbofuran, I + deltamethrin, I + demephion, I + demephion-O, I + demephion-S, I + demeton, I + demeton-methyl, I + demeton-O, I + demeton-O-methyl, I + demeton-S, I + demeton-S-methyl, I + demeton-S- methylsulphon, I + diafenthiuron, I + dialifos, I + diamidafos, I + diazinon, I + dicapthon, I + dichlofenthion, I + dichlorvos, I + dicliphos, I + dicresyl, I + dicrotophos, I + dicyclanil, I + dieldrin, I + diethyl 5-methylpyrazol-3-yl phosphate, I + diflubenzuron, I + dilor, I + dimefluthrin, I + dimefox, I + dimetan, I + dimethoate, I + dimethrin, I + dimethylvinphos, I + dimetilan, I + dinex, I + dinex-diclexine, I + dinoprop, I + dinosam, I + dinoseb, I + dinotefuran, I + diofenolan, I + dioxabenzofos, I + dioxacarb, I + dioxathion, I + disulfoton, I + dithicrofos, I + DNOC, I + doramectin, I + DSP, I + ecdysterone, I + El 1642, I + emamectin, I + emamectin benzoate, I + EMPC, I + empenthrin, I + endosulfan, I + endothion, I + endrin, I + EPBP, I + EPN, I + epofenonane, I + eprinomectin, I + esfenvalerate, I + etaphos, I + ethiofencarb, I + ethion, I + ethiprole, I + ethoate-methyl, I + ethoprophos, I + ethyl formate, I + ethyl-DDD, I + ethylene dibromide, I + ethylene dichloride, I + ethylene oxide, I + etofenprox, I + etrimfos, I + EXD, I + famphur, I + fenamiphos, I + fenazaflor, I + fenchlorphos, I + fenethacarb, I + fenfluthrin, I + fenitrothion, I + fenobucarb, I + fenoxacrim, I + fenoxycarb, I + fenpirithrin, I + fenpropathrin, I + fenpyrad, I + fensulfothion, I + fenthion, I + fenthion-ethyl, I + fenvalerate, I + fipronil, I + flonicamid, I + flubendiamide, I + flucofuron, I + flucycloxuron, I + flucythrinate, I + fluenetil, I + flufenerim, I + flufenoxuron, I + flufenprox, I + flumethrin, I + fluvalinate, I + FMC 1 137, I + fonofos, I + formetanate, I + formetanate hydrochloride, I + formothion, I + formparanate, I + fosmethilan, I + fospirate, I + fosthiazate, I + fosthietan, I + furathiocarb, I + furethrin, I + gamma-cyhalothrin, I + gamma-HCH, I + guazatine, I + guazatine acetates, I + GY-81 , I + halfenprox, I + halofenozide, I + HCH, I + HEOD, I + heptachlor, I + heptenophos, I + heterophos, I + hexaflumuron, I + HHDN, I + hydramethylnon, I + hydrogen cyanide, I + hydroprene, I + hyquincarb, I + imidacloprid, I + imiprothrin, I + indoxacarb, I + iodomethane, I + IPSP, I + isazofos, I + isobenzan, I + isocarbophos, I + isodrin, I + isofenphos, I + isolane, I + isoprocarb, I + isopropyl 0-(methoxy- aminothiophosphoryl)salicylate, I + isoprothiolane, I + isothioate, I + isoxathion, I + ivermectin, I + jasmolin I, I + jasmolin II, I + jodfenphos, I + juvenile hormone I, I + juvenile hormone II, I + juvenile hormone III, I + kelevan, I + kinoprene, I + lambda-cyhalothrin, I + lead arsenate, I + lepimectin, I + leptophos, I + lindane, I + lirimfos, I + lufenuron, I + lythidathion, I + m-cumenyl methylcarbamate, I + magnesium phosphide, I + malathion, I + malonoben, I + mazidox, I + mecarbam, I + mecarphon, I + menazon, I + mephosfolan, I + mercurous chloride, I + mesulfenfos, I + metaflumizone, I + metam, I + metam-potassium, I + metam-sodium, I + methacrifos, I + methamidophos, I + methanesulfonyl fluoride, I + methidathion, I + methiocarb, I + methocrotophos, I + methomyl, I + methoprene, I + methoquin-butyl, I + methothrin, I + methoxychlor, I + methoxyfenozide, I + methyl bromide, I + methyl isothiocyanate, I + methylchloroform, I + methylene chloride, I + metofluthrin, I + metolcarb, I + metoxadiazone, I + mevinphos, I + mexacarbate, I + milbemectin, I + milbemycin oxime, I + mipafox, I + mirex, I + monocrotophos, I + morphothion, I + moxidectin, I + naftalofos, I + naled, I + naphthalene, I + NC-170, I + NC-184, I + nicotine, I + nicotine sulfate, I + nifluridide, I + nitenpyram, I + nithiazine, I + nitrilacarb, I + nitrilacarb 1 : 1 zinc chloride complex, I + NNI-0101 , I + NNI-0250, I + nornicotine, I + novaluron, I + noviflumuron, I + 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate, I + 0,0- diethyl 0-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate, I + 0,0-diethyl 0-6-methyl-2- propylpyrimidin-4-yl phosphorothioate, I + Ο,Ο,Ο',Ο'-tetrapropyl dithiopyrophosphate, I + oleic acid, I + omethoate, I + oxamyl, I + oxydemeton-methyl, I + oxydeprofos, I + oxydisulfoton, I + pp'-DDT, I + para-dichlorobenzene, I + parathion, I + parathion-methyl, I + penfluron, I + pentachlorophenol, I + pentachlorophenyl laurate, I + permethrin, I + petroleum oils, I + PH 60-38, I + phenkapton, I + phenothrin, I + phenthoate, I + phorate+ TX, I + phosalone, I + phosfolan, I + phosmet, I +

phosnichlor, I + phosphamidon, I + phosphine, I + phoxim, I + phoxim-methyl, I + pirimetaphos, I + pirimicarb, I + pirimiphos-ethyl, I + pirimiphos-methyl, I + polychlorodicyclopentadiene isomers, I + polychloroterpenes, I + potassium arsenite, I + potassium thiocyanate, I + prallethrin, I + precocene I, I + precocene II, I + precocene III, I + primidophos, I + profenofos, I + profluthrin, I + promacyl, I + promecarb, I + propaphos, I + propetamphos, I + propoxur, I + prothidathion, I + prothiofos, I + prothoate, I + protrifenbute, I + pymetrozine, I + pyraclofos, I + pyrazophos, I + pyresmethrin, I + pyrethrin I, I + pyrethrin II, I + pyrethrins, I + pyridaben, I + pyridalyl, I + pyridaphenthion, I + pyrimidifen, I + pyrimitate, I + pyriproxyfen, I + quassia, I + quinalphos, I + quinalphos-methyl, I + quinothion, I + quintiofos, I + R-1492, I + rafoxanide, I + resmethrin, I + rotenone, I + RU 15525, I + RU 25475, I + ryania, I + ryanodine, I + sabadilla, I + schradan, I + sebufos, I + selamectin, I + Sl- 0009, I + SI-0205, I + SI-0404, I + SI-0405, I + silafluofen, I + SN 72129, I + sodium arsenite, I + sodium cyanide, I + sodium fluoride, I + sodium hexafluorosilicate, I + sodium pentachlorophenoxide, I + sodium selenate, I + sodium thiocyanate, I + sophamide, I + spinosad, I + spiromesifen, I + spirotetrmat, I + sulcofuron, I + sulcofuron-sodium, I + sulfluramid, I + sulfotep, I + sulfuryl fluoride, I + sulprofos, I + tar oils, I + tau-fluvalinate, I + tazimcarb, I + TDE, I + tebufenozide, I + tebufenpyrad, I + tebupirimfos, I + teflubenzuron, I + tefluthrin, I + temephos, I + TEPP, I + terallethrin, I + terbam, I + terbufos, I + tetrachloroethane, I + tetrachlorvinphos, I + tetramethrin, I + theta-cypermethrin, I + thiacloprid, I + thiafenox, I + thiamethoxam, I + thicrofos, I + thiocarboxime, I + thiocyclam, I + thiocyclam hydrogen oxalate, I + thiodicarb, I + thiofanox, I + thiometon, I + thionazin, I + thiosultap, I + thiosultap-sodium, I + thuringiensin, I + tolfenpyrad, I + tralomethrin, I + transfluthrin, I +

transpermethrin, I + triamiphos, I + triazamate, I + triazophos, I + triazuron, I + trichlorfon, I + trichlormetaphos-3, I + trichloronat, I + trifenofos, I + triflumuron, I + trimethacarb, I + triprene, I + vamidothion, I + vaniliprole, I + veratridine, I + veratrine, I + XMC, I + xylylcarb, I + YI-5302, I + zeta- cypermethrin, I + zetamethrin, I + zinc phosphide, I + zolaprofos and ZXI 8901 , I + cyantraniliprole, I + chlorantraniliprole, I + cyenopyrafen, I + cyflumetofen, I + pyrifluquinazon, I + spinetoram, I + spirotetramat, I + sulfoxaflor, I + flufiprole, I + meperfluthrin, I + tetramethylfluthrin, I + triflumezopyrim; Compositions comprising a molluscicide include I + bis(tributyltin) oxide, I + bromoacetamide, I + calcium arsenate, I + cloethocarb, I + copper acetoarsenite, I + copper sulfate, I + fentin, I + ferric phosphate, I + metaldehyde, I + methiocarb, I + niclosamide, I + niclosamide-olamine, I +

pentachlorophenol, I + sodium pentachlorophenoxide, I + tazimcarb, I + thiodicarb, I + tributyltin oxide, I + trifenmorph, I + trimethacarb, I + triphenyltin acetate and triphenyltin hydroxide, I + pyriprole;

Compositions comprising a nematicide include l+ AKD-3088, I + 1 ,2-dibromo-3-chloropropane, I + 1 ,2-dichloropropane, I + 1 ,2-dichloropropane with 1 ,3-dichloropropene, I + 1 ,3-dichloropropene, I + 3,4-dichlorotetrahydrothiophene 1 , 1-dioxide, I + 3-(4-chlorophenyl)-5-methylrhodanine, I + 5-methyl-6- thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid, I + 6-isopentenylaminopurine, I + abamectin, I + acetoprole, I + alanycarb, I + aldicarb, I + aldoxycarb, I + AZ 60541 , I + benclothiaz, I + benomyl, I +

butylpyridaben, I + cadusafos, I + carbofuran, I + carbon disulfide, I + carbosulfan, I + chloropicrin, I + chlorpyrifos, I + cloethocarb, I + cytokinins, I + dazomet, I + DBCP, I + DCIP, I + diamidafos, I + dichlofenthion, I + dicliphos, I + dimethoate, I + doramectin, I + emamectin, I + emamectin benzoate, I + eprinomectin, I + ethoprophos, I + ethylene dibromide, I + fenamiphos, I + fenpyrad, I +

fensulfothion, I + fosthiazate, I + fosthietan, I + furfural, I + GY-81 , I + heterophos, I + iodomethane, I + isamidofos, I + isazofos, I + ivermectin, I + kinetin, I + mecarphon, I + metam, I + metam-potassium, I + metam-sodium, I + methyl bromide, I + methyl isothiocyanate, I + milbemycin oxime, I + moxidectin, I + Myrothecium verrucaria composition, I + NC-184, I + oxamyl, I + phorate, I + phosphamidon, I + phosphocarb, I + sebufos, I + selamectin, I + spinosad, I + terbam, I + terbufos, I + tetrachlorothiophene, I + thiafenox, I + thionazin, I + triazophos, I + triazuron, I + xylenols, I + YI-5302 and zeatin, I + fluensulfone;

Compositions comprising a synergist include I + 2-(2-butoxyethoxy)ethyl piperonylate, I + 5-(1 ,3- benzodioxol-5-yl)-3-hexylcyclohex-2-enone, I + farnesol with nerolidol, I + MB-599, I + MGK 264, I + piperonyl butoxide, I + piprotal, I + propyl isomer, I + S421 , I + sesamex, I + sesasmolin and I + sulfoxide; Compositions comprising an animal repellent include 1+ anthraquinone, I + chloralose, I + copper naphthenate, I + copper oxychloride, I + diazinon, I + dicyclopentadiene, I + guazatine, I + guazatine acetates, I + methiocarb, I + pyridin-4-amine, I + thiram, I + trimethacarb, I + zinc naphthenate and I + ziram;

Further compositions include I + Brofluthrinate, I + Cycloxaprid, I + Diflovidazine, I + Flometoquin, I + Fluhexafon, I + Guadipyr, I + Plutella xylostella Granulosis virus, I + Cydia pomonella Granulosis virus, I + Harpin, I + Imicyafos, I + Heliothis virescens Nucleopolyhedrovirus, I + Heliothis punctigera Nucleopolyhedrovirus, I + Helicoverpa armigera Nucleopolyhedrovirus, I + Helicoverpa zea

Nucleopolyhedrovirus, I + Spodoptera frugiperda Nucleopolyhedrovirus, I + Plutella xylostella

Nucleopolyhedrovirus, I + Pasteuria nishizawae , I + p-cymene, I + Pyflubumide, I + Pyrafluprole, I + pyrethrum, I + QRD 420, I + QRD 452, I + QRD 460, I + Terpenoid blends, I + Terpenoids, I + Tetraniliprole, and I + oterpinene;

Composition also include mixtures of compound of formula I and an active substance referenced by a code, such as I + code AE 1887196 (BSC-BX60309), I + code NNI-0745 GR, I + code IKI-3106, I + code JT-L001 , I + code ZNQ-08056, I + code IPPA152201 , I + code HNPC-A9908 (CAS: [66041 1-21- 2]), I + code HNPC-A2005 (CAS: [860028-12-2]), I + code JS1 18, I + code ZJ0967, I + code ZJ2242, I + code JS71 19 (CAS: [929545-74-4]), I + code SN-1 172, I + code HNPC-A9835, I + code HNPC- A9955, I + code HNPC-A3061 , I + code Chuanhua 89-1 , I + code IPP-10, I + code ZJ3265, I + code JS91 17, I + code SYP-9080, I + code ZJ3757, I + code ZJ4042, I + code ZJ4014, I + code ITM-121 , I + code DPX-RAB55 (DKI-2301 ), I + code Me5382, I + code NC-515, I + code NA-89, I + code MIE- 1209, I + code MCI-8007, I + code BCS-CL73507, I + code S-1871 , I + code DPX-RDS63, and I + code AKD-1 193.

Thus, in one embodiment 44, the active ingredient mixture of the compounds according to any one of embodiments 1 to 37 with active ingredients described above comprises a compound according to any one of embodiments 1 to 37 and an active ingredient as described above preferably in a mixing ratio of from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10:1 to 1 : 10, very especially from 5: 1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4: 1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 : 150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are by weight. In embodiment 45, the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body. The mixtures comprising a compound according to any one of embodiments 1 to 37 and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds according to any one of embodiments 1 to 37 and the active ingredients as described above is not essential for working the present invention.

The compositions according to embodiment 44 can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. The compositions according to embodiment 44 are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention.

The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha. A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.

The compounds according to any one of embodiments 1 to 37 and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.

In embodiment 46, the invention therefore relates to a method for the protection of plant propagation material from the attack by pests, which comprises treating the propagation material or the site, where the propagation material is planted, with a compound according to any one of embodiments 1 to 37 or with a composition according to embodiment 42 or 44, which comprises at least one compound according to any one of embodiments 1 to 37, as active ingredient and at least one auxiliary composition.

The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.

The present invention also comprises seeds coated or treated with or containing a compound of formula I. The term "coated or treated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with a compound of formula (I). Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound according to any one of embodiments 1 to 37. Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound according to any one of embodiments 1 to 37 can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the

sowing/planting of the seeds.

Experimental

Preparatory Examples: The following examples are intended to illustrate the invention and are not to be construed as being limitations thereon. "Mp" means melting point in °C. H NMR measurements were recorded on a Brucker 400MHz spectrometer, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated. LC MS Method A: Standard:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation

Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode- array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3 , 1.8 μηη, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH: gradient: gradient: 0 min 0% B, 100%A; 1.2-1.5min 100% B; Flow (ml/min) 0.85.

LC MS Method B: Standard long:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation

Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode- array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μηη, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05% HCOOH: gradient: gradient: 0 min 0% B, 100% A; 2.7-3.0min 100% B; Flow (ml/min) 0.85.

LC MS Method C: Unpolar:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation

Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode- array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μηη, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05% HCOOH, B= Acetonitrile + 0.05% HCOOH: gradient: gradient: 0 min 40% B, 60% A; 1.2-1.5 min 100% B; Flow (ml/min) 0.85.

MS Method D:

The mass spectra were obtained on a Finnigan LCQ-DUO spectrometer using electrospray ionization. UPLC-MS Method E:

Mass Spectrometer : Acquity SDS Mass Spectrometer from Waters

HPLC : UPLC Ή' class

Optimized Mass Parameter:- lonisation method : Electrospray (ESI). Polarity : Positive and Negative Polarity Switch. Scan Type : Full Scan. Capillary (kV) : 3.00. Cone Voltage (V) : 41.00. Source Temperature (°C) : 150.

Desolvation Gas Flow (L/Hr) : 1000. Desolvation Temperature (°C) : 500. Gas Flow @ Cone (L/Hr) 50. Mass range : 1 10 to 800 Da. PDA Wavelength range : 210 to 400 nm.

Optimized Chromatographic parameter:- Gradient conditions:

Solvent A: Water with 0.1 % formic acid : Acetonitrile : : 95 : 5 v/v

Solvent B: Acetonitrile with 0.05% formic acid

Time (minutes) A (%) B (%) Flow rate (ml/min)

0 90 10 0.8

0.2 50 50 0.8

0.7 0 100 0.8

1.3 0 100 0.8

1.4 90 10 0.8

1.6 90 10 0.8

Column : Acquity UPLC HSS T3 C18

Column length : 30 mm. Internal diameter of column : 2.1 mm. Particle Size : 1.8 μιτι. Column oven temperature : 40°C

LC-MS Method F:

Mass Spectrometer : 6410 Triple Quadruple Mass Spectrometer from Agilent Technologies HPLC : Agilent 1200 Series HPLC

Optimized Mass Parameter:

lonisation method : Electrospray (ESI). Polarity : Positive and Negative Polarity Switch. Scan Type : MS2 Scan. Capillary (kV) : 4.00. Fragmentor (V) : 100.00. Gas Temperature (°C) : 350. Gas Flow (L/min) : 1 1. Nebulizer Gas (psi) : 45. Mass range : 1 10 to 1000 Da. DAD Wavelength range : 210 to 400 nm.

Optimized Chromatographic Parameter:

Gradient conditions:

Solvent A: Water with 0.1 % formic acid : Acetonitrile : : 95 : 5 v/v

Solvent B: Acetonitrile with 0.1 % formic acid

Time (minutes) A (%) B (%) Flow rate (ml/min)

0 90 10 1.8

0.9 0 100 1.8

1.8 0 100 1.8

2.2 90 10 1.8 2.5 90 10 1.8

Column : KINETEX EVO C18

Column length : 50 mm. Internal diameter of column : 4.6 mm. Particle Size : 2.6 μιτι. Column oven temperature : 40°C.

EXAMPLE V. Preparation of 1-(2-isopropylphenvn-3-[6-[1 -[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3- yll-2-quinolyllthiourea (compound P1.4)

Step A-1 : Preparation of 2-oxo-1 H-quinoline-6-carbonitrile

To a solution of 6-bromo-1 H-quinolin-2-one (20.0 g, 89.0 mmol) in NMP (80 mL) was added CuCN (12.8 g, 142 mmol) followed by heating the reaction mixture at 150° C for 16 h. The reaction mixture was cooled to room temperature, poured on to crushed ice, resulted solids filtered, and dried under vacuum to afford 2-oxo-1 H-quinoline-6-carbonitrile (15.0 g) as brown solid.

Ή NMR (300 MHz, DMSO-c/e): δ 12.15 (s, 1 H), 8.24 (s, 1 H), 7.91 (d, 2H), 7.41 (s, 1 H), 6.63 (s, 1 H). MS (method D) m/z: 171 .1 [M + H] ⁺ Step A-2: Preparation of 2-chloroquinoline-6-carbonitrile

A suspension of 2-oxo-1 H-quinoline-6-carbonitrile (15.0 g, 88.0 mmol) in POC (130 mL) was heated at 120° C for 16 h. The reaction mixture was cooled to room temperature, poured on to crushed ice, resulted solids filtered and dried under vacuum to afford 2-chloroquinoline-6-carbonitrile (14.0 g) as brown solid.

Ή NMR (300 MHz, DMSO-c/e): δ 8.73 (s, 1 H), 8.57 (d, 1 H), 8.09-8.16 (m, 2H), 7.78 (d, 1 H).

MS (method D) m/z: 189.1 [M + H] ⁺

Step A-3: Preparation of tert-butyl N-(6-cyano-2-quinolyl)carbamate

A suspension of 2-chloroquinoline-6-carbonitrile (14.0 g, 75.0 mmol) in 1 , 4 dioxane (230 mL) was charged with tert-butyl carbamate (9.60 g, 82.0 mmol) and NaOH (4.46 g, 1 16 mmol) at room temperature followed by degassing with argon for 10 min. Pd(OAc)2 (0.50 g, 0.75 mmol) and

Xanthphos (0.86 g, 1 .48 mmol) were added to the reaction mixture and heated at 100 °C for 16 h. The reaction mixture was cooled to room temperature, filtered through celite bed, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography to afford tert-butyl N-(6-cyano-2-quinolyl)carbamate (10.0 g) as an off white solid.

H NMR (300 MHz, CDCIs): δ 8.26 (d, 1 H), 8.13-8.18 (m, 2H), 8.04 (s, 1 H), 7.84 (d, 1 H), 7.78 (d, 1 H),

7.75 (d, 1 H), 1.51 (s, 9H).

MS (method D) m/z: 270.1 [M + H] ⁺

Step A-4: Preparation of tert-butyl N-(6-carbamoyl-2-quinolyl)carbamate

A solution of tert-butyl N-(6-cyano-2-quinolyl)carbamate (7.00 g, 26.0 mmol) in DMSO (70 mL) was charged with K2CO3 (3.50 g) followed by H2O2 (21.0 mL) dropwise at 0°C over 10 min. The reaction mixture was heated to room temperature and stirred for 2 h. The reaction mixture was cooled to 0° C, quenched with ice cold water (400 mL), resulted solids were filtered and dried under vacuum to afford tert-butyl N-(6-carbamoyl-2-quinolyl)carbamate (7.10 g) as an off white solid.

H NMR (300 MHz, DMSO-c/e): δ 10.26 (s, 1 H), 8.43 (d, 1 H), 8.35 (d, 1 H), 8.09-8.13 (m, 1 H), 7.77 (d, 1 H), 7.47 (s, 1 H),

MS (method D) m/z:288.1 [M + H] ⁺

Step A-5: Preparation of tert-butyl N-[6-[(E)-dimethylaminomethylenecarbamoyl]-2-quinolyl]carbam ate

A suspension of tert-butyl N-(6-carbamoyl-2-quinolyl)carbamate (7.10 g, 25.0 mmol) in DMF'DMA (35 mL) was heated at 90 °C for 4 h. The reaction mixture was cooled to room temperature and concentrated under reduced pressure to afford tert-butyl N-[6-[(E)- dimethylaminomethylenecarbamoyl]-2-quinolyl]carbamate (7.50 g, crude) as an off white solid.

H NMR (300 MHz, DMSO-c/e): δ 10.23 (s, 1 H), 8.72 (t, 2H), 8.36-8.46 (m, 2H), 8.09(d, 1 H), 7.76 (d,

1 H), 3.22 (d, 6H), 1.50 (s, 9H). MS (method D) m/z: 343.1 [M + H] ⁺

Step A-6: Preparation of tert-butyl N-[6-(1 H-1 ,2,4-triazol-3-yl)-2-quinolyl]carbamate

A solution of tert-butyl N-[6-[(E)-dimethylaminomethylenecarbamoyl]-2-quinolyl]carbam ate (7.50 g, 19.7 mmol) in acetic acid (75 ml_) was charged with hydrazine hydrate (1.00 mL, 19.7 mmol) over 10 min at room temperature. The reaction mixture was heated at 80 °C for 1 h. The reaction mixture was concentrated under reduced pressure, triturated with MTBE (100 mL) and was dried under vacuum to afford to afford tert-butyl N-[6-(1 H-1 ,2,4-triazol-3-yl)-2-quinolyl]carbamate (4.00 g) as an off-white solid.

H NMR (300 MHz, DMSO-c/e): δ 10.22 (s, 1 H), 8.52 (d, 2H), 8.41 (d, 1 H), 8.30 (dd, 1 H), 8.08 (d, 1 H),

7.83 (d, 1 H), 1.50 (s, 9H).

MS (method D) m/z: 312.1 [M + H] ⁺

Step A-7: Preparation of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine

A solution of tert-butyl N-[6-(1 H-1 ,2,4-triazol-3-yl)-2-quinolyl]carbamate (4.00 g, 12.8 mmol) in DMF: water (80 mL, 4: 1 ) was charged with compound 1-iodo-4-(trifluoromethoxy)benzene (3.70 g, 12.8 mmol), CS2CO3 (8.32 g, 25.6 mmol) and 8-hydroxy quinoline (0.43 g, 2.90 mol) and the mixture was degased with argon for 10 min. Cul (0.73 g, 3.80 mol) was added to the reaction mixture and heated at 150 °C for 16 h. The reaction mixture was cooled to room temperature, quenched with water (300 mL) and extracted with EtOAc (2 ^χ 300 mL). The combined organic layers were washed with water (100 mL) and brine (100 mL), dried over anhydrous Na2S04, and concentrated under reduced pressure. The residue was purified by column chromatography to afford 6-[1 -[4- (trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine

(2.90 g) as an off white solid.

Ή NMR (300 MHz, DMSO-c/e): δ 9.41 (s, 1 H), 8.39 (d, 1 H), 8.20 (d, 1 H), 8.03-8.18 (d, 3H), 7.63 (d, 2H), 7.55 (d, 1 H), 6.81 (d, 1 H), 6.63 (s, 1 H).

MS (method D) m/z: 371.9 [M + H] ⁺

Step A-8: Preparation of 1-(2-isopropylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiourea

A suspension of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine (200 mg, 0.54 mmol) in THF (6.0 mL) was charged with NaH (32 mg, 0.81 mmol, 60 % in mineral oil) in portions wise at 0° C and stirred for 30 minutes. A solution of 1-isopropyl-2-isothiocyanato-benzene (477 mg, 2.69 mmol) in THF (6 mL) was added to the reaction mixture and allowed stirred at 60° C for 16 h. The reaction mixture was cooled to 0 °C, quenched with water (10 mL) and extracted with EtOAc (2 ^χ 50 mL). The combined organic layers were washed with water (20 mL) and brine (20 mL), dried over anhydrous Na2S04, and concentrated under reduced pressure. The residue was purified by flash column chromatography to afford 1-(2-isopropylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4- triazol-3-yl]-2-quinolyl]thiourea (55.0 mg) as an off white solid.

H NMR (300 MHz, DMSO-c/e): δ 13.81 (s, 1 H), 1 1 .30 (s, 1 H), 9.47 (s, 1 H), 8.67 (d, 1 H), 8.55 (d, 1 H), 8.39 (d, 1 H), 8.1 1 (d, 2H), 7.92 (d, 1 H), 7.64 (d, H), 7.51 (d, 2H), 7.43 (d, 1 H), 7.25-7.30 (m,2H), 3.18- 3.27 (m, 1 H), 1.26 (d, 6H).

MS (method D) m/z: 548.9 [M + H] ⁺

EXAMPLE 2: Preparation of 1-(2-isopropylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3- yll-2-quinolyllurea (compound P1.3)

A solution of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine (100 mg, 0.269 mmol, example 1 , step A-7) in CH3CN (5.0 mL) was charged with K2CO3 (1 1 1 mg, 0.81 mmol) and a solution of 1-isocyanato-2-isopropyl-benzene (52 mg, 0.322 mmol) in CH3CN (5.0 mL). The reaction mixture was stirred at room temperature for 16 h. The resulted solids were filtered and dried under vacuum to afford 1-(2-isopropylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]urea (50 mg) as an off white solid.

Ή NMR (300 MHz, DMSO-c/e): δ 1 1.59 (s, 1 H), 10.26 (s, 1 H), 9.47 (s, 1 H), 8.63 (s, 1 H), 8.45-8.49 (m, 2H), 8.09-8.17 (q, 2H), 8.10 (dd, 1 H), 7.86 (d, 1 H), 7.64 (d, 2H), 7.39 (d, 2H), 7.12-7.7.27 (m, 2H), 3.50-3.54 (m, 1 H), 1.34 (d, 6H).

MS (method D) m/z: 532.8 [M + H] ⁺ EXAMPLE 3: Preparation of 3-(2-isopropylphenvn-N-[6-[1-[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3- yll-2-quinolyll-1 ,3-thiazetidin-2-imine (compound P2.1 )

A solution of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine (100 mg, 0.269 mmol, example 1 , step A-7) in butan-2-one (5.0 mL) was charged with diiodomethane (0.122 g, 0.456 mmol) and K2CO3 (0.202 g, 1.458 mmol). The reaction mixture was stirred at 55°C overnight. After cooling, the solution was diluted with dichloromethane. The organic phase was washed with sodium thiosulfate and brine, dried over MgSC , filtered and evaporated. The crude product was purified by column chromatography to give 3-(2-isopropylphenyl)-N-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4- triazol-3-yl]-2-quinolyl]-1 ,3-thiazetidin-2-imine (60 mg) as a solid (mp: 102-3°C).

H NMR (400 MHz, CDCI3): δ 8.60 (s, 1 H), 8.53 (d, 1 H), 8.42 (dd, 1 H), 8.06 (d, 1 H), 7.96 (d, 1 H), 7.82 (m, 2H), 7.35 - 7.42 (m, 4H), 7.35 (t, 1 H), 7.22 (m, 1 H), 7.10 (d, 1 H), 5.01 (s, 2H), 3.33 (sept, 1 H), 1.28 (d, 6H).

LC/MS (method B) m/z: 561 [M + H] ⁺ , Rt = 2.47 min.

EXAMPLE 4: Preparation of 3-(2-isopropylphenyl)-4-methyl-N-[6-[1-[4-(trifluoromethoxy) phenyll-1 ,2,4- triazol-3-yll-2-quinolyllthiazol-2-imine (compound P2.2)

A solution of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine (200 mg, 0.365 mmol, example 1 , step A-7) in butan-2-one (5.0 ml) was charged with triethylamine (0.105 ml, 0.729 mmol) and chloropropan-2-one (0.036 ml, 0.456 mmol). The mixture was stirred at RT for 24h. The solution was diluted with dichloromethane. The organic phase was washed with water, dried over MgSC , filtered and evaporated. The crude product was purified by column chromatography to give 3- (2-isopropylphenyl)-4-methyl-N-[6-[1-[4-(trifluoromethoxy)ph enyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]thiazol- 2-imine (58 mg) as a solid.

Ή NMR (400 MHz, CDCI3): δ 8.60 (s, 1 H), 8.50 (s, 1 H), 8.41 (dd, 1 H), 8.08 (d, 1 H), 7.92 (d, 1 H), 7.85 (d, 2H), 7.51 (m, 2H), 7.35 - 7.45 (m, 3H), 7.17 (t, 1 H), 7.00 (d, 1 H), 6.21 (s, 1 H), 2.59 (sept, 1 H), 1.21 and 1.15 (2d, 6H), 1.14 (d, 6H). LC/MS (method B) m/z: 587 [M + H] ⁺ , Rt = 2.26 min.

EXAMPLE 5: Preparation of (2Z)-3-(2-isopropylphenvn-2-[[6-[1 -[4-(trifluoromethoxy)phenyll-1 ,2,4- triazol-3-yll-2-quinolylliminolthiazolidin-4-one (compound P2.3) and (2E)-2-(2-isopropylphenyl)inriino- 3-[6-[1 -[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3-yll-2-quinolyllthiazolidin-4-one (compound P2.4)

(P2.3) (P2.4)

A solution of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinolin-2-amine (200 mg , 0.365 mmol, example 1 , step A-7) in butan-2-one (5.0 ml_) was charged with triethylamine (0.105 ml, 0.729 mmol) and chloracetyl chloride (0.052 g, 0.456 mmol). The mixture was stirred at 60°C for 6h. The solution was diluted with dichloromethane. The organic phase was washed with water, dried over MgSC , filtered and evaporated. The crude mixture was purified by column chromatography to give (2Z)-3-(2-isopropylphenyl)-2-[[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]imino]thiazolidin-4-one (60 mg, compound P2.3) and (2E)-2-(2-isopropylphenyl)imino-3-[6-[1 - [4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2-quinolyl]thiazolidin-4-one (35 mg, compound P2.4).

(2Z)-3-(2-isopropylphenyl)-2-[[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]imino]thiazolidin-4-one (compound P2.3)

Ή NMR (400 MHz, CDCIs): δ 8.63 (s, 1 H), 8.61 (s, 1 H), 8.52 (dd, 1 H), 8.10 - 8.14 (m, 2H), 7.85 (d ,

2H), 7.51 (m, 2H), 7.43 (m, 2H), 7.38 (m, 1 H), 7.20 (m, 1 H), 7.14 (d, 1 H), 4.03 (s, 2H), 2.87 (sept, 1 H), 1 .24 (m, 6H).

LC/MS (method B) m/z: 589 [M + H] ⁺ , Rt = 2.30 min. (2E)-2-(2-isopropylphenyl)imino-3-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-2- quinolyl]thiazolidin-4-one (compound P2.4)

H NMR (400 MHz, CDCI3): δ 8.77 (s, 1 H), 8.66 (s, 1 H), 8.62 (dd , 1 H), 8.49 (d, 1 H), 8.25 (d, 1 H), 7.85 (m, 2H), 7.57 (d, 1 H), 7.43 (d, 2H), 7.26 (t, 1 H), 7.1 1 - 7.15 (m, 2H), 6.89 (d, 1 H), 4.10 (s, 2H), 2.99 (sept, 1 H), 1 .16 (d, 6H).

LC/MS (method B) m/z: 589 [M + H] ⁺ , Rt = 2.24 min. EXAMPLE 6: Preparation of 1-(2,6-dimethylphenvn-3-[6-[1 -[4-qrifluoromethoxy)phenyll-1 ,2,4-triazol-3- yllquinazolin-2-yllthiourea (component P2.5) and 1-(2,6-dimethylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)- henyll-1 ,2,4-triazol-3-yllquinazolin-2-yllurea (component P2.6)

(P2.5) (P2.6)

Ste B-1 : Preparation of 3-bromo-1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazole

To a mixture of 1 -iodo-4-(trifluoromethoxy)benzene (3 g, 10.416 mmol) in methylsulfinylmethane (24 mL) was added 3-bromo-1 H-1 ,2,4-triazole (3.1 g) under nitrogen atmosphere followed by addition of cesium carbonate (6.7 g, 20.833 mmol) and copper iodide (0.4 g, 2.083 mmol). The reaction mass was stirred at 130°C for 18 hours in seal tube. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 70 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (3 g).

H NMR (400 MHz, (CD ₃ ) ₃ SO): δ 9.38 - 9.25 (m, 1 H), 7.98 - 7.92 (m, 2H), 7.65 - 7.53 (m, 2H) LC/MS (method E) m/z: 308 [M + H] ⁺ , Rt = 0.94 min. -2: Preparation of 6-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)quinazolin-2-amine

In a two neck RB to a solution of 6-bromoquinazolin-2-amine (1.5 g, 6.695 mmol) in 1 ,4-Dioxane (20 mL) was added potassium acetate(1.0 g, 10.042 mmol) and 4,4,5,5-tetramethyl-2-(4,4,5,5- tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 ,3,2-dioxaborolane(2.6 g, 10.042 mmol). The reaction mixture was degassed with nitrogen for 20 min followed by addition of Pd(PPfi3)2Cl2 (231 mg, 0.335 mmol). The reaction mixture was again degassed for 10 min and then refluxed at 100°C for overnight.

Reaction mass was diluted with water and extracted by DCM (3 x 50 mL). The combined organic layers were dried over anhydrous sodium sulphate and concentrated under reduced pressure and purified by column chromatography to obtain the title compound as solid (700 mg).

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 9.20 - 9.14 (m, 1 H), 8.17 (s, 1 H), 7.86 (br d, 1 H), 7.43 - 7.29 (m, 1 H), 7.08 - 6.98 (m, 2H), 1.32 (s, 12H). LC/MS (method F) m/z: 272 [M + H] ⁺ , Rt = 1 .12 min.

Ste B-3: Preparation of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinazolin-2-amine

A mixture of 6-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)quinazolin-2-amine (100 mg, 0.3689 mmol) and 3-bromo-1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazole (1 10 mg, 0.3689 mmol) ) in 1 ,4-Dioxane (2 mL) was added sodium bicarbonate (90 mg , 1 .107 mmol) dissolved in water (1 mL) followed by addition of Pd(PPh3)2Cl2 (25 mg, 0.0368 mmol;). Reaction mixture was then degassed for 10 min and cooked in microwave at 150°C for 1 hour after which the reaction mixture was poured in water and and extracted with ethyl acetate (3 x 20 mL). The combined organic layer were dried over anhydrous sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (190mg).

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 9.48 - 9.39 (m, 1 H), 9.28 (s, 1 H), 8.54 (d , 1 H), 8.43 - 8.34 (m, 1 H), 8.14 - 8.04 (m, 2H), 7.71 - 7.60 (m, 2H), 7.54 (d, 1 H), 7.1 1 - 6.96 (m, 2H)

LC/MS (method E) m/z: 373 [M + H] ⁺ , Rt = 0.75 min.

Step B-4: Preparation of 1 -(2,6-dimethylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3- yl]quinazolin-2-yl]thiourea (component P2.5) and 1 -(2,6-dimethylphenyl)-3-[6-[1 -[4- (trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinazolin-2-yl]urea (Component P2.6)

To a stirring solution of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinazolin-2-amine (300 mg, 0.8058 mmol) in tetrahydrofuran (6 mL) under nitrogen atmosphere was added sodium hydride (50 mg, 1 .612 mmol) at 0°C followed by 2-isothiocyanato-1 ,3-dimethyl-benzene (0.4 mL, 2.417 mmol) and reaction was refluxed at 60°C for 3 hours. Reaction mass was then diluted with water and extracted with ethyl acetate (3 x 25 mL). Combined organic layers were then dried over anhydrous sodium sulphate and concentrated under reduced pressured followed by column chromatography of the crude compound to obtain the two title compounds as solids (150 mg and 70 mg respectively)

Com ound P2.5:

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 2.26 (s, 6H), 7.17 (s, 3H), 7.66 (d , 2H), 8.08 - 8.19 (m, 3H), 8.62 (d , 1 H), 8.84 (s, 1 H), 9.51 (s, 1 H), 9.73 (s, 1 H), 1 1 .34 (s, 1 H), 12.85 (s, 1 H) LC/MS (method F) m/z: 536 [M + H] ⁺ , Rt = 1 .72 min. om ound P2.6:

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 2.30 (s, 6H), 7.15 (s, 3H), 7.66 (d, 2H), 8.07 (d1 H), 8.13 (d, 2H), 8.60 (d, 1 H), 8.81 (s, 1 H), 9.51 (s, 1 H), 9.68 (s, 1 H), 10.44 (s, 1 H), 1 1.12 (s, 1 H)

LC/MS (method F) m/z: 520 [M + H] ⁺ , Rt = 1 .68 min.

EXAMPLE 7: Preparation of (2Z)-3-(2,6-dimethylphenylH-methyl-2-[6-[1 -[4-(trifluoromethoxy)phenyll- 1 2,4-triazol-3-yllquinazolin-2-yllimino-thiazolidin-4-ol (compound P2.7)

(P2.7)

To the mixture of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]- 1 ,2,4-triazol-3- yl]quinazolin-2-yl]thiourea (60 mg, 0.1 12 mmol), methyl ethyl ketone (4 mL), triethylamine (0.05 mL, 0.3361 mmol) and tetrahydrofuran(1 mL) was added 1-chloropropan-2-one (0.03 mL, 0.2241 mmol). The reaction mass was then heated at 60°C for overnight in a sealed tube. The reaction mass was then diluted with water and extracted with DCM (3 x 15 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (20 mg).

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 1.45 (s, 3H), 2.21 (s, 3H), 2.40 (s, 3H), 3.40 (d, 1 H), 3.62 (d, 1 H), 7.24 - 7.33 (m, 3H), 7.67 (d, 2H), 7.94 (d, 1 H), 8.13 (d, 2H), 8.62 (d, 1 H), 8.74 (s, 1 H), 9.41 (s, 1 H), 9.52 (s, 1 H)

LC/MS (method E) m/z: 592 [M + H] ⁺ , Rt = 1 .12 min.

EXAMPLE 8: Preparation of 3-(2,6-dimethylphenyl)-N-[6-[1 -[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-

3-yllquinazolin-2-yll-1 ,3-thiazetidin-2-imine (compound P2.8)

(P2.8)

A suspension of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]- 1 ,2,4-triazol-3- yl]quinazolin-2-yl]thiourea (400 mg, 0.747 mmol), butan-2-one (15 mL), tetrahydrofuran (3 mL), potassium carbonate (600 mg, 3.735 mmol) and di-iodomethane (0.2 mL, 1.494 mmol) was heated at 60°C for overnight. The reaction mass was then diluted with water and extracted with DCM (3 x 25 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (120 mg). Ή NMR (400 MHz, CDCI ₃ : δ 2.40 (s, 6H), 4.92 (s, 2H), 7.03 - 7.13 (m, 2H), 7.17 (d, 1 H), 7.42 (d, 2H), 7.79 - 7.98 (m, 3H), 8.56 - 8.67 (m, 3H), 9.32 (s, 1 H)

LC/MS (method F) m/z: 548 [M + H] ⁺ , Rt = 1 .70 min.

EXAMPLE 9: Preparation of (2Z)-3-(2,6-dimethylphenyl)-2-[6-[1-[4-(trifluoromethoxy)phe nyll-1 ,2,4- triazol-3-yllquinazolin-2-yllimino-thiazolidin-4-one(compoun d P2.9) and (2Z)-2-(2,6-dimethyl- phenyl)imino-3-[7-[1-[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3-yllquinazolin-2-yllthiazolidin-4-one

(com ound P2.10)

(P2.9) (P2.10)

In a 2 neck round bottom flask equipped with a two way stopcock and a condenser was added 1 -(2,6- dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinazolin-2-yl]thiourea (200 mg, 0.3735 mmol) methyl ethyl ketone (4 mL), THF (5 ml ), triethylamine (0.2 mL, 1.120 mmol) and 2- chloroacetyl chloride (0.44 ml, 0.4482 mmol) one after the other. Reaction was allowed to stir for 30 min at room temperature and then heated at 70 °C for overnight. The reaction mass was then diluted with water and extracted with DCM (3 x 25 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the two title compounds both as solids (46 mg and 27 mg respectively) Compound P2.9:

Ή NMR (400 MHz, CDCI ₃ : δ 2.18 (s, 6H), 4.09 (s, 2H), 6.90 - 6.95 (m, 1 H), 6.98 - 7.03 (m, 2H), 7.43 (d, 2H), 7.85 (d, 2H), 8.25 (d, 1 H), 8.66 (s, 1 H), 8.82 - 8.92 (m, 2H), 9.67 (s, 1 H)

LC/MS (method F) m/z: 576 [M + H] ⁺ , Rt = 1 .67 min.

Com ound P2.10:

H NMR (400 MHz, CDCI ₃ : δ 2.23 (s, 6 H,) 4.05 (s, 2 H), 7.16 - 7.22 (m, 2 H), 7.27 - 7.30 (m, 1 H), 7.38 - 7.46 (m, 2 H), 7.80 - 7.88 (m, 2 H), 8.02 - 8.09 (m, 1 H), 8.61 - 8.76 (m, 3 H), 9.39 - 9.47 (m, 1 H)

LC/MS (method F) m/z: 576 [M + H] ⁺ , Rt = 1 .67 min.

EXAMPLE 10: Preparation of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyll- 1 ,2,4-triazol- 3- llquinoxalin-2-yllthiourea (compound P2.1 1 )

(P2.1 1 )

Ste C-1 : Preparation of 6-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)quinoxalin-2-amine

To the solution of tert-butyl N-(6-bromoquinoxalin-2-yl)carbamate (400 mg, 1.234 mmol) in 1 ,4- Dioxane (10 mL) was added potassium acetate(180 mg, 2.008 mmol) and 4,4,5,5-tetramethyl-2- (4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 ,3,2-dioxaborolane (442 mg, 1.851 mmol). To the reaction mixture was then added Pd(PPfi3)2Cl2 (1 10 mg, 0.0617 mmol) and it was refluxed at 100°C for overnight The reaction mass was then diluted with water and extracted with dichloromethane (3 25 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (125 mg). Ή NMR (400 MHz, CDCI ₃ : δ 1.39 (s, 12H), 5.19 (br. s, 2H), 7.63 (d, 1 H), 7.92 - 8.03 (m, 1 H), 8.35 (s, 1 H), 8.41 (s, 1 H)

LC/MS (method E) m/z: 272 [M + H] ⁺ , Rt = 0.77 min.

Ste C-2: Preparation of 6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinoxalin-2-amine

A mixture of 4,4,5, 5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)quinoxalin-2-amine (250 mg, 0.9222 mmol), 1 ,4-Dioxane (4 mL), 3-bromo-1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazole (283 mg, 0.922 mmol), sodium bicarbonate solution(230 mg, 2.767 mmol in 1 mL water) was degassed with nitrogen for 20 min and then was added Pd(PPh3)2Cl2 (64 mg, 0.0922 mmol) .Reaction was again degassed for 10 min and then was cooked in microwave at 140°C for 1 hour. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 25 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (80 mg).

H NMR (400 MHz, (CD ₃ ) ₃ SO: δ 9.48 - 9.38 (m, 1 H), 8.50 - 8.43 (m, 1 H), 8.36 (s, 1 H), 8.26 (dd, 1 H), 8.15 - 8.05 (m, 2H), 7.69 - 7.60 (m, 3H), 7.23 - 7.13 (m, 2H)

LC/MS (method E) m/z: 373 [M + H] ⁺ , Rt = 0.82 min.

Step C-3: Preparation of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]- 1 ,2,4-triazol-3- l]quinoxalin-2-yl]thiourea (compound P2.1 1 )

To a stirring solution of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]quinoxalin-2-amine (350 mg, 0.9401 mmol) in tetrahydrofuran (16 mL) under nitrogen atmosphere was added sodium hydride (150 mg, 3.760 mmol) at 0°C followed by 2-isothiocyanato-1 ,3-dimethyl-benzene (0.6 mL, 3.760 mmol). The reaction mixture was then heated at 60°C for 3 hours. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 25 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (325 mg).

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 2.27 (s, 6H), 7.10 - 7.33 (m, 3H), 7.64 (d, 2H), 8.04 - 8.16 (m, 2H), 8.16 - 8.30 (m, 1 H), 8.44 (dd, 1 H), 8.63 (d, 1 H), 8.96 (s, 1 H), 9.49 (s, 1 H), 1 1.65 (s, 1 H), 12.56 - 12.83 (m, 1 H) LC/MS (method E) m/z: 534 [M - H] ⁺ , Rt = 1 .14 min.

EXAMPLE 1 1 : Preparation of 3-(2,6-dimethylphenvn-N-[6-[1-[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol- -yllquinoxalin-2-yll-1 ,3-thiazetidin-2-imine (compound P2.12)

(P2.12)

To a mixture of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]- 1 ,2,4-triazol-3- yl]quinoxalin-2-yl]thiourea (250 mg, 0.4669 mmol), butan-2-one (15 mL) and potassium carbonate (380 mg, 2.334 mmol) was added di-iodomethane (0.12 mL, 0.9337 mmol). The reaction mixture was then heated at 60°C for overnight. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 20 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid(130 mg).

Ή NMR (400 MHz, CDCI ₃ : δ 2.43 (s, 6H), 5.01 (s, 2H), 7.17 (m, 2H), 7.27 (m, 1 H), 7.43 (d, 2H), 7.86 (d, 2H), 7.97(d, 1 H), 8.50 (dd, 1 H), 8.59 (s, 1 H), 8.64 (s, 1 H), 8.82 (d, 1 H)

LC/MS (method E) m/z: 548 [M + H] ⁺ , Rt = 1 .18 min.

EXAMPLE 12: Preparation of 1-(2,6-dimethylphenvn-3-[6-[1-[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol- 3-yll-1 ,3-benzothiazol-2-yllurea (compound P2.16) and 1-(2,6-dimethylphenyl)-3-[6-[1-[4-

(P2.16) (P17) Step D-1 : Preparation of 6-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 ,3-benzothiazol-2-amine

To the stirring solution of 6-bromo-1 ,3-benzothiazol-2-amine (5 g, 21.825 mmol) in 1 ,4-Dioxane (80 mL) was added potassium acetate (3 g, 32.737 mmol) and 4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl- 1 ,3,2-dioxaborolan-2-yl)-1 ,3,2-dioxaborolane (8.3 g, 32.737 mmol). The reaction mixture was degassed with nitrogen for 20 min followed by addition of Pd(PPh3)2Cl2 (850 mg, 1 .0912 mmol). The reaction mixture was again degassed for 10 min and then refluxed at 100°C for overnight. The reaction mass was then diluted with water and extracted with dichloromethane (3 x 100 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (5 g).

H NMR (400 MHz, CDCI ₃ : δ 1 .35 (s, 12H), 5.45 (br. s, 2H), 7.53 (d, 1 H), 7.75 (d, 1 H), 8.06 (s, 1 H) LC/MS (method E) m/z: 277 [M + H] ⁺ , Rt = 0.96 min.

Ste D-2: Synthesis of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-1 ,3-benzothiazol-2-amine

To a solution of 6-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 ,3-benzothiazol-2-amine (1 g , 3.621 mmol) in 1 ,4-Dioxane (12 mL) was added 3-bromo-1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazole (1 .1 1 g, 3.621 mmol) and sodium bicarbonate solution(900 mg , 10.86 mmol in 3 mL water). Then reaction mixture was degassed with nitrogen, followed by addion of Pd(PPfi3)2Cl2 (250 mg, 0.3621 mmol) and was degassed again for 10min. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 50 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the title compound as solid (350 mg).

LC/MS (method E) m/z: 378 [M + H] ⁺ , Rt = 1 .05 min.

Step D-3: Preparation of 1 -(2,6-dimethylphenyl)-3-[6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]- 1 ,3-benzothiazol-2-yl]urea (compound P2.16) and 1 -(2,6-dimethylphenyl)-3-[6-[1 -[4- ( nd P2.17)

To a stirring solution of 6-[1 -[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-1 ,3-benzothiazol-2-amine (350 mg, 0.9276 mmol) in tetrahydrofuran (6 mL) under nitrogen atmosphere was added sodium hydride (180 mg, 3.71 1 mmol) at 0°C followed by addition of 2-isothiocyanato-1 ,3-dimethyl-benzene (0.8 mL, 4.638 mmol). The reaction mixture was then heated at 60°C for overnight. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 30 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the two title compounds both as solids (1 15 mg and 145 mg respectively).

Compound P2.16:

Ή NMR (400 MHz, (CD ₃ ) ₃ SO: δ 2.24 (s, 6H), 7.13 (s, 3H), 7.64 (d, 2H), 7.79 (d, 1 H), 8.06 - 8.18 (m, 3H), 8.37 (br. s., 1 H), 8.63 (s, 1 H), 9.42 (s, 1 H), 1 1.02 (s, 1 H)

LC/MS (method E) m/z: 525 [M + H] ⁺ , Rt = 1 .21 min.

Compound P2.17:

H NMR (400 MHz, CDCI ₃ : δ 2.40 (s, 6H), 7.20 - 7.27 (m, 3H), 7.43 (d, 2H), 7.80 - 7.86 (m, 3H), 8.32 (d, 1 H), 8.62 (s, 2H)

LC/MS (method E) m/z: 541 [M + H] ⁺ , Rt = 1 .25 min.

EXAMPLE 13: Preparation of 3-(2,6-dimethylphenyl)-N-[6-[1-[4-(trifluoromethoxy)phenyll- 1 ,2,4-triazol- 3-yll-1 ,3-benzothiazol-2-yll-1 ,3-thiazetidin-2-imine(compound P2.14) and N-(2,6-dimethylphenyl)-3-[6- [1-[4-(trifluoromethoxy)phenyll-1 ,2,4-triazol-3-yll-1 ,3-benzothiazol-2-yll-1 ,3-thiazetidin-2-imine (com ound P2.15)

(P2.14) (P2.15)

To a mixture of 1 -(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyl]-1 ,2,4-triazol-3-yl]-1 ,3- benzothiazol-2-yl]thiourea (300 mg, 0.5549 mmol), butan-2-one (15 mL) and tetrahydrofuran (3 mL) was added potassium carbonate (450 mg, 2.775 mmol) and di-iodomethane (0.13 mL, 1.1 10 mmol). The reaction mixture was the heated at 60°C for overnight. The reaction mass was then diluted with water and extracted with ethylacetate (3 x 30 mL). The combined organic layers were then dried over sodium sulphate and concentrated under reduced pressure followed by column chromatography to obtain the two title compounds both as solids (15 mg and 20 mg respectively).

Compound P2.14:

H NMR (400 MHz, CDCI ₃ : δ 2.40 (s, 6H), 4.92 (s, 2H), 7.10 - 7.17 (m, 2H), 7.19 - 7.26 (m, 1 H), 7.40 (d, 2H), 7.83 (dd, 3H), 8.15 - 8.25 (m, 1 H), 8.51 - 8.60 (m, 2H)

LC/MS (method F) m/z: 553 [M + H] ⁺ , Rt = 1 .79 min.

Compound P2.15:

Ή NMR (400 MHz, CDCI ₃ : δ 2.27 (s, 6H), 5.21 (s, 2H), 6.94 - 7.02 (m, 1 H), 7.08 (d, 2H), 7.41 (d, 2H), 7.82 (d, 2H), 7.87 (d, 1 H), 8.30 (d, 1 H), 8.60 (d, 2H)

LC/MS (method F) m/z: 553 [M + H] ⁺ , Rt = 1 .87 min.

EXAMPLE 14:Preparation of 1-(2,6-dimethylphenyl)-3-[6-[1-[4-(trifluoromethoxy)phenyll- 1 ,2,4-triazol- -yll-2-naphthyllthiourea (compound P2.13)

(P2.13)

This compound was prepared in a similar way as compound P2.1 1 (Example 10)

H NMR (400 MHz, (CD ₃ ) ₃ SO: δ 2.17 - 2.33 (m, 6H), 6.98 - 7.21 (m, 3H), 7.56 - 7.78 (m, 3H), 7.89 -

8.32 (m, 6H), 8.58 - 8.76 (m, 1 H), 9.46 (s, 1 H)

LC/MS (method E) m/z: 534 [M + H] ⁺ , Rt = 1 .62 min.

Table P1 :

wherein R ^a , A ¹ , A ² , A ³ , A ⁴ , A ⁵ , A ⁶ , R ^b , R ^c , R ^d and X are as defined below:

R ^a A ¹ A ² A ³ A ⁴ A ⁵ A ⁶ R ^b R ^c R ^d X LC MS / NMR Mp /°C

P1.1 OCF ₃ N CH CH CH CH CH CH ₃ H CH ₃ 0

P1.2 OCF3 N CH CH CH CH CH CH ₃ H CH ₃ S 535 [M + H] ⁺ 202-3

Method B

P1.3 OCF3 N CH CH CH CH CH iPr H H 0 532.8 [M + H] ⁺ 230-5

Method D

P1.4 OCF3 N CH CH CH CH CH iPr H H S 548.9 [M + H] ⁺ 215-20

Method D

P1.5 OCF3 N CH CH CH CH CH CH ₃ H CI S

P1.6 OCF3 CH CH CH CH CH CH CH ₃ H CH ₃ S

P1.7 OCF3 CH CH CH CH CH CH iPr H H S

P1.8 OCF3 CH CH CH CH CH CH iPr H H 0

P1.9 OCF3 CH CH CH CH CH CH CH ₃ H CI S

P1.10 OCF3 N N CH CH CH CH CH ₃ H CH ₃ S

P1.1 1 OCF3 N N CH CH CH CH iPr H H S

P1.12 OCF3 N N CH CH CH CH iPr H H 0

P1.13 OCF3 N N CH CH CH CH CH ₃ H CI S

P1.14 OCF3 N CH N CH CH CH CH ₃ H CH ₃ S

P1.15 OCF3 N CH N CH CH CH iPr H H s

P1.16 OCF3 N CH N CH CH CH iPr H H 0

P1.17 OCF3 N CH N CH CH CH CH ₃ H CI s

P1.18 OCF3 N CH CH CH CH N CH ₃ H CH ₃ s

P1.19 OCF3 N CH CH CH CH N iPr H H s

P1.20 OCF3 N CH CH CH CH N CH ₃ H CI s

P1.21 OCF3 N CH CH CH CH N CH ₃ H CI 0

P1.22 OCF3 CH CH CH CH CH N iPr H H s

P1.23 OCF3 CH CH CH N CH CH iPr H H s

Table P2: P2.7 592 (M+H)+ 196-8

Rt = 1.12 min

Method E

P2.8 548 (M+H)+ 227-9

Rt = 1.70 min

Method F

P2.9 576 (M+H)+

Rt = 1.67 min

Method F

P2.10 576 (M+H)+

Rt = 1.67 min

Method F

F

P2.1 1 534 (M-H)+ 217-9

Rt = 1.14 min

Method E

P2.12 548 (M+H)+ 197-9

Rt = 1.18 min

Method E

P2.13 534 (M+H)+

Rt = 1.62 min

Method F

Biological Examples (% = percent by weight, unless otherwise specified)

Example B1 : Spodoptera littoralis (Egyptian cotton leaf worm)

Cotton leaf discs were placed on agar in 24-well microtiter plates and sprayed with agueous test solutions prepared from 10,000 ppm DMSO stock solutions. After drying, the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feedant effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of Spodoptera littoralis by a test sample is when at least one of mortality, anti-feedant effect, and growth inhibition is higher than the untreated sample.

The following compounds resulted in at least 80% control at an application rate of 200 ppm: P1.2, P1.4, P2.1 , P2.2, P2.3, P2.4, P2.9, P2.10, P2.1 1 , P2.12, P2.14, P2.13 and P2.17.

Example B2: Plutella xylostella (Diamond back moth)

24-well microtiter plates with artificial diet were treated with agueous test solutions prepared from 10,000 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P1.2, P1 .3, P1.4, P2.1 , P2.2, P2.3. P2.4, P2.9, P2.10, P2.1 1 , P2.13, P2.14 and P2.17. Example B3: Diabrotica balteata (Corn root worm)

Maize sprouts, placed on an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10,000 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P1.2, P1 .3, P1.4, P2.1 , P2.2, P2.3. P2.4, P2.7, P2.9, P2.10, P2.1 1 , P2.13 and P2.17.

Example B4: Euschistus heros

Soybean leaf on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf were infested with N-2 nymphs. The samples were assessed for growth inhibition in comparison to untreated samples 5 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P2.4, P2.7 and P2.17.

Example B5: Thrips tabaci (Onion thrips)

Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with a thrips population of mixed ages. The samples were assessed for mortality 6 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P2.4 and P2.14.

Example B6: Frankliniella occidentalis (Western flower thrips)

Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10Ό00 DMSO stock solutions. After drying the leaf discs were infested with a Frankliniella population of mixed ages. The samples were assessed for mortality 7 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P2.1 , P2.2, P2.3, P2.4 and P2.12.